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ABSTRACT 
 
Dectin-1 Expression is Altered by Fungal Infection, Polymicrobial Sepsis, and Glucan 
Administration 
 
by 
Tammy R. Ozment-Skelton 
 
Glucans are fungal cell wall PAMPs that promote survival in polymicrobial and candidal sepsis.  
Dectin-1 is the primary PRR for glucans.  The goals of the present study were to characterize 1) 
the effects of fungal infection on Dectin-1; 2) the effects of polymicrobial sepsis in the presence 
and absence of glucan on Dectin-1; 3) the effects of systemic administration of glucans on 
Dectin-1; and 4) the intracellular trafficking of glucans. Mice were either systemically infected 
with Candida albicans, or made septic by CLP with and without glucan phosphate (GP) 
injection, or injected with GP.  Flow cytometry was performed to assess cell surface Dectin-1 
expression.  C. albicans sepsis resulted in an increase in the percentage of Dectin-1 positive 
(Dectin+) blood and splenic leukocytes by increasing the percentage of neutrophils.  C. albicans 
infection increased the percentage of Dectin+ splenic T cells.  CLP decreased the percentage of 
highly Dectin-1 positive leukocytes in the blood by decreasing the percentage of Dectin+ 
neutrophils.  GP treatment in sepsis further decreased the percentages of Dectinhigh blood 
leukocytes and Dectin+ neutrophils.  CLP decreased the percentage of Dectin+ splenic leukocytes 
by decreasing the percentage of splenic macrophages.  GP administration to CLP mice further 
decreased the percentage of Dectin+ splenocytes by decreasing the percentage of Dectin+ 
macrophages.  Administration of GP resulted in a prolonged decrease in the percentage of 
Dectinhigh blood leukocytes.  The changes in Dectin-1 expression with GP were because of 
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decreases in the percentage of Dectin+ neutrophils and monocytes.   In the trafficking studies, 
macrophages were incubated with fluorescent labeled glucans and then stained for intracellular 
organelles and signal transduction molecules.  Cells were imaged using confocal microscopy.  
GP is internalized by clathrin and trafficked to the Golgi apparatus. GP internalization is 
regulated but not dependent on caveolin-1.  GP co-localized with SRA, TLR2, and PI3K/p85.  
The trafficking of laminarin and particulate glucan is similar. We speculate that loss of cell 
surface Dectin-1 may be important in the protection conferred by glucans in sepsis.  
Additionally, intracellular trafficking and interaction with signaling components may be 
important steps in modulation of cellular function by glucan-pattern recognition receptor 
complexes.  
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CHAPTER 1 
 
INTRODUCTION 
  
The Innate Immune System 
 
 The primary job of the mammalian immune system is to protect against infectious 
disease.  The immune system can be divided into two interrelated branches, the adaptive or 
specific branch and the innate or non-specific branch.  The adaptive immune response is 
mediated by T and B lymphocytes that express highly specific receptors against an individual 
organism.  Over the course of infection, new generations of lymphocytes express receptors that 
are even more specific to the pathogen by mutation of the genes for the receptors and selection of 
the cells expressing receptors that best recognize the pathogen.  The innate immune system on 
the other hand consists of a myriad of barriers and cellular responses that are not specific to the 
offending organism.  The cells of the innate immune system are integral to a protective immune 
response.  They consist of phagocytic and non-phagocytic cells and are often found at locations 
of pathogen entry.  These cells not only engulf and destroy pathogens, but they are also 
responsible for mediating the inflammatory response by producing mediators (cytokines and 
chemokines) that attract and activate immune cells. These responses are immediate, and 
therefore the innate immune system is the first line of defense against invading pathogens.  
Additionally, the innate immune system plays an important role in the regulation of the adaptive 
immune response by production of cytokines and chemokines and presentation of antigen.  The 
resolution of most infections requires the activity of both the innate and adaptive immune 
systems. 
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Pattern Recognition Receptors
 The cells of the innate immune system, including monocytes, macrophages, neutrophils, 
dendritic cells, and endothelial cells, are the first cells to respond to invading pathogens.  These 
cells recognize pathogens by virtue of evolutionarily conserved germline encoded receptors 
known as pattern recognition receptors (PRRs) (Gordon 2002; Akira and Hemmi 2003).  These 
receptors bind to molecules unique to and necessary for the survival of microbes known as 
pathogen associated molecular patterns (PAMPs) (Gordon 2002; Akira and Hemmi 2003).  
Many PRRs have been found to also bind to endogenous ligands that are frequently molecules 
released by damaged host tissues ( Johnson et al. 2002; Tsan and Gao 2004). The interaction of 
PRRs with their ligands is rapid, specific, and gives rise to a diverse array of innate immune 
responses that are directed at controlling and/or eliminating the pathogen and thus protecting the 
host from infection (Gordon 2002; Akira and Hemmi 2003).   The most studied of the families of 
PRRs are the toll-like receptors (TLR), and the most studied of this family of 11 members is 
TLR4.  The best known PAMP for TLR4 is lipopolysaccharide (LPS), an integral component of 
gram negative bacteria (Akira and Hemmi 2003).  Upon binding LPS, TLR4 mediates a signal 
cascade that results in the activation of several transcription factors including nuclear factor 
(NF)-κB (Figure 1) (Akira and Takeda 2004).  This transcription factor stimulates the 
transcription of genes encoding inflammatory cytokines and chemokines (Akira and Takeda 
2004).  In phagocytes, TLR4 also mediates uptake of LPS (Husebye et al. 2006).  Mice that lack 
TLR4 are unable to mount an effective immune response to LPS (Hoshino et al. 1999).   Many of 
the other TLRs use similar signaling pathways to TLR4 (Figure 1) ( Akira and Hemmi 2003; 
Akira and Takeda 2004). 
Figure 1  Schematic of toll like receptor signaling pathways (adapted from Pathway 
Builder Tool™) 
   
 
Dectin-1.  Not all PRRs are TLRs.  Dectin-1 is one non-TLR PRR.  Dectin-1 is the 
primary PRR for (1→3)/(1→6)-β-linked glucans (Brown and Gordon 2001; Willment et al. 
2001; Brown et al. 2002; Taylor et al. 2002; Brown et al. 2003).  When it was discovered, 
however, Dectin-1 was not originally thought to be a PRR (Ariizumi et al. 2000).  Dectin-1 was 
discovered by Ariizumi et al. using cDNA subtractive cloning (Ariizumi et al. 2000) in which 
mRNAs from a macrophage cell line were compared to those of a dendritic cell (DC) line.  
17 
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Dectin-1 was found to be one of the mRNAs exclusively expressed by the DC cell line.  Upon 
expressing the protein for Dectin-1, the amino acid sequence for Dectin-1 was discovered 
(Ariizumi et al. 2000).  As the then unknown protein contained a carbohydrate recognition 
domain that was homologous to those found in C type lectins, it was designated DC-associated 
C-type lectin-1 or Dectin-1 (Ariizumi et al. 2000).  Further studies by the Ariizumi group 
determined that the expressed protein would bind to an unknown ligand on T cells.  Binding of 
Dectin-1 to activated T lymphocytes stimulated replication.  Therefore, the authors proposed that 
Dectin-1 was a co-stimulatory molecule for T lymphocytes (Ariizumi et al. 2000).  Brown et 
al.later discovered that Dectin-1 is also a PRR for glucans by screening a macrophage expression 
library with zymosan, a fungal cell wall extract that is primarily composed of glucan (Brown et 
al. 2001).  In this study, Brown et al. determined that Dectin-1 transfected cells would bind to 
free glucans and to glucans present in the fungal cell wall (Brown et al. 2001).  They also 
determined that the glucan binding site is independent of the site that binds to and stimulates T 
lymphocytes (Brown et al. 2001).  These pioneering studies have resulted in an explosion of 
activity in the study of Dectin-1. 
  Dectin-1 is a type II transmembrane receptor (Brown and Gordon 2001; Brown et al. 
2003; Gantner et al. 2003; Rogers et al. 2005).  Extracellularly it contains a single C-type lectin-
like carbohydrate recognition domain and 1 of the 2 alternatively spliced isoforms contains a 
cysteine-free stalk region (Figure 2) (Ariizumi et al. 2000; Willment et al. 2001; Willment et al. 
2005; Heinsbroek et al. 2006).  The lack of cysteine residues in the stalk or the lack of a stalk 
region suggests that Dectin-1 does not dimerize (Heinsbroek et al. 2006).  Dectin-1 has a 
tyrosine based activation motif (ITAM) in the cytoplasmic tail (Figure 2) (Brown and Gordon 
2001; Willment et al. 2001; Brown et al. 2002; Taylor et al. 2002; Brown et al. 2003; Gantner et 
al. 2003).  This motif is required for cellular activation (Brown et al. 2003; Gantner et al. 2003).  
Upon binding glucan, phosporylation of tyrosine residues present in the ITAM result in the 
generation of signal cascades (Gantner et al. 2003; Underhill et al. 2005).  These cascades are 
Figure 2  Structure of full length murine Dectin-1 (A) and the 
truncated splice variant (B) (Adapted from Brown et al. 
2003) 
currently under investigation; however, phosphorylation results in the interaction and activation 
of SH2-domain containing protein spleen tyrosine kinase (SYK) (Figure 3) (Rogers et al. 2005; 
Underhill et al. 2005).  SYK then mediates the induction of the respiratory burst, a microbial 
killing mechanism, in macrophages (Figure 3) (Rogers et al. 2005; Underhill et al. 2005).  
Dectin-1 also mediates a signaling cascade via TLR2, another member of the TLR family 
(Figure 3)  (Brown et al. 2003; Gantner et al. 2003).  This interaction results in NF-κB activation 
and tumor necrosis factor (TNF) α production (Figure 3) (Brown et al. 2003; Gantner et al. 
2003).  Finally, Dectin-1 is also able to mediate an inflammatory response to glucans by 
stimulating NF-κB activity and TNFα production in a TLR2 independent manner; however, this 
pathway is poorly understood (Figure 3) (Brown et al. 2003). 
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Figure 3 Schematic of Dectin-1 mediated signaling pathways 
Dectin-1 is expressed by monocytes, neutrophils, macrophages, and, at lower levels, by 
dendritic cells and subpopulations of T cells (Willment et al. 2001; Brown et al. 2002; Taylor et 
al. 2002).  The amount of Dectin-1 expressed by macrophages is influenced by tissue location as 
well as activation status (Taylor et al. 2002; Willment et al. 2003).  Alveolar macrophages, 
which are present at a point of pathogen entry, express high levels of Dectin-1, as do 
inflammatory macrophages (Taylor et al. 2002).  Dectin-1 expression is altered by cytokines and 
microbial products (Willment et al. 2003).  Granulocyte monocyte colony stimulating factor 
(GM-CSF) enhances Dectin-1 expression and function in activated macrophages, whereas 
interleukin (IL)-10 reduces Dectin-1 expression by macrophages (Willment et al. 2003).  LPS 
20 
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also reduces Dectin-1 expression by macrophages (Willment et al. 2003).  Whether other 
cytokines and chemokines or microbial products will have similar effects has not been explored. 
Dectin-1 will bind free glucans as well as whole Candida albicans and Saccharomyces 
cerevisiae cells in a glucan dependent manner and, upon binding, mediates rapid internalization 
of the Dectin-1/glucan complex (Brown and Gordon 2001; Willment et al. 2001; Brown et al. 
2002; Taylor et al. 2002; Brown et al. 2003; Herre et al. 2004).  Internalization is not required for 
signal generation, but the type of signal generated by Dectin-1 may depend on internalization 
(Brown et al. 2003; Herre et al. 2004).  When Dectin-1 is internalized with a biologically active 
glucan, glucan phosphate, Dectin-1 is degraded, and new receptors must be synthesized prior to 
cell surface expression (Herre et al. 2004).  When Dectin-1 is internalized with an inactive 
glucan, laminarin, the Dectin-1 is rapidly recycled to the cell surface (Herre et al. 2004).  The 
differences in trafficking may be related to differences in activity.  
 
Pathogen Associated Molecular Patterns
 PAMPs are molecules found exclusively in microbes.  They are integral to microbial 
survival and are, therefore, not alterable by the organism.  These characteristics make PAMPs 
ideal targets for the mammalian immune system.  Microbial restricted carbohydrates, lipids, 
nucleic acids, and proteins can be PAMPs.  LPS is one of the most studied PAMPs of Gram 
negative bacteria, but most microbes have many PAMPs.  Gram positive bacteria contain 
lipoproteins, peptidoglycan, and lipoteichoic acid which are TLR2 ligands (Akira and Hemmi 
2003; Akira and Takeda 2004).  Viral genetic material can also act as a PAMP.  CpG DNA is a 
ligand for TLR9 and double stranded RNA is a ligand for TLR3 (Akira and Hemmi 2003; Akira 
and Takeda 2004).  Fungi have a variety of PAMPs in their cell walls including mannan, which 
binds to the mannose receptor and to DC-SIGN (Cambi et al. 2003; Allavena et al. 2004), and 
glucans, which are ligands for Dectin-1 (Brown and Gordon 2001; Willment et al. 2001; Brown 
et al. 2002; Taylor et al. 2002; Brown et al. 2003). 
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(1→3)-β-D-glucan.  Glucans are a major cell wall component of both pathogenic and 
saprophytic fungi, some bacteria, and plants (Chauhan et al. 2002; Williams et al. 2003). They 
are polymers of glucose that can exist as a non-branched (1-3)-β-linked backbone or as the 
backbone with (1-6)-β-linked branches (Ensley et al. 1994; Lowman et al. 1998) either in a 
single helix or triple helical conformation (Figure 4).  Glucans have been reported to be masked 
within the cell wall of fungi, but are exposed at traumatized areas of the cell wall such as bud 
scars (Figure 5) (Gantner et al. 2005).  They are also released from the fungal cell wall, and 
increased levels of glucans can be found in the blood of patients with fungal infection (Mori et 
al. 1997; Nakamura et al. 1998; Hiyoshi et al. 1999).  Interestingly, elevated glucan levels are 
also found circulating in the blood of critically ill patients, regardless of the presence of fungal 
infection (Mori et al. 1997; Nakamura et al. 1998; Hiyoshi et al. 1999; Digby et al. 2003).  
Studies suggest that the source of these glucans is the gastrointestinal tract, as glucans have been 
shown to be absorbed from the gut (Rice et al. 2005b).  The consequences of circulating glucans 
are not known. 
A. 
Candida albicans 
B. 
Figure 4  Molecular structure of (1→3)/(1 
→6)−b-D-glucan  A.  Linear structure of 
(1→3)/(1 →6)−b-D-glucan with the backbone 
chain (BC), reducing terminus (RT), second 
from the reducing terminus (SRT), and the non-
reducing terminus (NRT) indicated.  B.  Three 
dimensional representation of the triple helical 
conformation of glucan (Adapted from Lowman 
et al. 2003). 
Figure 5  Schematic representation of 
the location of glucan in the fungal cell 
wall (Adapted from Shepherd 1987) 
 
Glucans bind to multiple PRRs including Dectin-1 (Brown et al. 2002; Brown et al. 2003; 
Gantner et al. 2003), type A scavenger receptor (SR-A) (Rice et al. 2002), and complement 
receptor (CR) 3 (Xia et al. 1999).  They have also been reported to interact with 
lactosylceramide, a glycosphingolipid that forms lipid rafts (Sato et al. 2006).  They are able to 
activate macrophages (Williams et al. 1983; Williams et al. 1996), activate and attract 
neutrophils (Williams et al. 1988; Tsikitis et al. 2004; Sato et al. 2006), and stimulate 
inflammatory cytokine production by activation of NF-κB (Abel and Czop 1992; Williams et al. 
1996; Brown et al. 2003; Gantner et al. 2005).  Based upon the presence of glucans in the fungal 
23 
cell wall and their ability to induce an inflammatory response, glucans are considered to be 
important in the innate immune response against fungal infection (Abel and Czop 1992).   
Pure glucans have been shown to be biological response modifiers ( Williams et al. 1978; 
Williams et al. 1982; Williams et al. 1988; Williams et al. 1989; Williams et al. 1991b; Lasarow 
et al. 1992; Williams et al. 1999b; Cheung et al. 2002; Hong et al. 2004).  Glucans were 
originally thought to be primarily immunostimulants.  They have been shown to increase 
resistance to challenge with bacteria or fungi primarily by their activating effects on 
macrophages and neutrophils (Williams et al. 1982; Williams et al. 1988) They have also been 
reported to be potent adjuvants (Williams et al. 1989; Cheung et al. 2002; Hong et al. 2004).  
Recent studies by Cheung et al.and Hong et al. have demonstrated that administration of glucans 
enhances the tumoricidal activity of anti-tumor antibodies (Cheung et al. 2002; Hong et al. 
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Figure 6  Glucan phosphate administration in mice 
improves survival in polymicrobial sepsis (Adapted from 
Williams et al. 1999b) 
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2004).  Glucans also facilitate wound repair by stimulating macrophages and collagen 
biosynthesis (Portera et al. 1997; Wei et al. 2002).  Interestingly, glucans have non-
immunomostimulatory effects as well.  Administration of glucan phosphate (GP) significantly 
increases survival outcome in mice subjected to cecal ligation and puncture (CLP) induced 
polymicrobial sepsis (Figure 6) (Williams et al. 1999b).  Glucans have also been shown to 
reduce cardiac ischemia/reperfusion injury (Li et al. 2003).  An excessive inflammatory response 
contributes to the pathophysiology of both of these conditions (Williams et al. 1999b).  Glucans 
have been found to blunt this response (Williams et al. 1999b).  As the first step in the 
modulation of cellular function by glucans is binding of the glucan by membrane associated 
PRRs (Mueller et al. 1996; Mueller et al. 2000; Rice et al. 2002), it is likely that the PRRs for 
glucans play a significant role in both immunostimulatory and immunomodulatory responses. 
Differences in size and conformation between different glucans result in different 
biologic activities and binding affinities for Dectin-1.  For instance, GP, a soluble glucan derived 
from S. cerevisiae with a molecular weight of approximately 150,000 kDa, binds Dectin-1 with 
an IC50 of 2.7pM (Figure 7A) (manuscript in preparation).  Laminarin, a soluble glucan derived 
from Laminaria digitata with a molecular weight of approximately 7500 kDa, binds Dectin-1 
with an affinity of almost 100 times less that of GP (Figure 7A, manscript in preparation).  The 
in vitro effects of these different glucans on Dectin-1 have also been found to be different (Herre 
et al. 2004).  GP induces internalization and degradation of Dectin-1 after binding, while 
laminarin induces internalization, but the receptor recycles quickly back to the cell surface 
(Herre et al. 2004).  Finally, in vivo laminarin is not protective in polymicrobial sepsis (Figure 
7B), though GP is.  The molecular basis of the differences in activity between different glucans 
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in vivo is not yet known, but the differences in binding affinity to Dectin-1 and effects on Dectin-
1 trafficking are likely involved. 
 
Intracellular Trafficking of PRR/PAMP Complexes 
 As previously mentioned, PRRs mediate internalization of PAMPs.  The complex is then 
trafficked within the cell.  Ideally, the microbe is destroyed within a phagolysosome, and the 
receptor is either transported back to the cell surface or is degraded.  The exact molecular 
mechanisms for internalization and trafficking vary by PRR and may vary by which PAMP is 
bound.  Additionally, the signal generated by the PRR/PAMP interaction may be dependent on 
trafficking.  There are two primary mechanisms for receptor/ligand internalization:  clathrin-
mediated and clathrin independent lipid raft-mediated (Le Roy and Wrana, 2005). 
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Figure 7  Different glucans have varying affinities for Dectin-1 and differing in vivo activities  
A.  IC50 for each glucan was determined by surface plasmon resonance.  The binding curves 
for glucan phosphate and laminarin demonstrate a higher Dectin-1 binding affinity for GP 
than for laminarin.  B.  The survival curve for CLP induced polymicrobial sepsis in the 
presence and absence of laminarin treatment reveals that laminarin is not protective in sepsis. 
Manuscript in preparation. 
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 Clathrin Mediated Internalization.  The internalization of many nutrients, pathogens, 
growth factors, and receptors is clathrin dependent (Le Roy and Wrana, 2005).  Clathrin is a 
cytoplasmic protein that interacts with ligand-bound receptor via adapter proteins to form a coat 
along the plasma membrane (Le Roy and Wrana, 2005).  The clathrin coated pit then mediates 
internalization of the plasma membrane and the receptor/ligand complex (Figure 8A) (Le Roy 
and Wrana, 2005).  Upon internalization, the resulting vesicle is uncoated and fuses with early 
endosomes (Figure 8A) (Le Roy and Wrana, 2005).  The fate of the receptor/ligand complex 
then varies.  The receptor may dissociate from the ligand, usually in late endosomes (Figure 8A) 
(Le Roy and Wrana, 2005).  The receptor then may recycle via recycling endosomes to the cell 
surface or be degraded (Figure 8A) (Le Roy and Wrana, 2005).  Alternately, the receptor/ligand 
complex may be trafficked to lysosomes where it and the ligand are degraded (Figure 8A) (Le 
Roy and Wrana, 2005).  Studies have also found that the complex may be trafficked to the Golgi 
apparatus (Figure 8A) (Le Roy and Wrana, 2005).  Therefore, the fate of the receptor/ligand 
complex after clathrin mediated internalization varies widely depending on the receptor and 
ligand involved. 
 
 Non-clathrin Dependent Internalization.  Evidence suggests that clathrin independent 
internalization is mediated by lipid rafts (Nichols 2003; Le Roy and Wrana, 2005).  Lipid rafts 
are cholesterol rich plasma membrane micro-domains (Nichols 2003; Le Roy and Wrana, 2005).  
They are able to segregate membrane components and are thought to be platforms for signal 
transduction by cell surface receptors (Le Roy and Wrana, 2005).  Caveolae are one type of lipid 
raft micro-domain (Williams and Lisanti 2004c).  They are membrane invaginations that are 
dependent on caveolin for their formation (Le Roy and Wrana, 2005).  Lipid raft mediated 
internalization may be mediated by caveolin, but caveolin independent mechanisms also occur 
(Le Roy and Wrana, 2005).  Upon internalization by caveolin the receptor/ligand complex is 
trafficked in a vesicle known as a caveosome (Figure 8B) (Le and Nabi, 2003; Nichols 2003; Le 
Roy and Wrana, 2005).  The caveosome traffics to the endosomal pathway as well as to the 
Golgi apparatus and the endoplasmic reticulum (Figure 8B) (Le and Nabi, 2003; Le Roy and 
Wrana, 2005).  Non-caveolin dependent lipid raft mediated internalization is poorly understood 
at this time. 
 
 
A. B.
Figure 8  Schematic representation of the 2 types of receptor mediated internalization, clathrin 
mediated and lipid raft dependent 
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Internalization and Trafficking of PRR/PAMP Complexes.  The mechanisms of intracellular 
trafficking have primarily been investigated for receptors that interact with endogenous ligands 
such as growth factor and cytokine receptors; however, the means of internalization and 
trafficking of PRRs are slowly coming to light.  The majority of studies have investigated the 
trafficking pathways of the TLRs, specifically TLR2 and TLR4 (Thieblemont and Wright 1999; 
Triantafilou et al. 2002; Triantafilou et al. 2004a; Triantafilou et al. 2004b).  For instance, when 
TLR2 interacts with lipoteichoic acid, the complex is internalized by a lipid raft dependent 
mechanism and is then trafficked to the Golgi apparatus (Triantafilou et al. 2004a).  Trafficking 
of LPS by TLR4 is a bit more complex ( Thieblemont and Wright 1999; Triantafilou et al. 2002; 
Triantafilou et al. 2004a; Triantafilou et al. 2004b).  TLR4 has been found to migrate to lipid 
rafts upon interacting with LPS ( Triantafilou et al. 2002; Triantafilou et al. 2004b); however, 
internalization of the complex is inhibited by loss of clathrin and is retained with disruption of 
the lipid raft (Husebye et al. 2006).  This indicates that TLR4/LPS uptake is mediated by 
clathrin.  The TLR4/LPS complex then localizes to the early endosomes (Husebye et al. 2006).  
At later time intervals the receptor and ligand dissociate, with the LPS being found in the Golgi 
apparatus, while TLR4 is transported to the lysosome where it is degraded (Thieblemont and 
Wright 1999; Latz et al. 2002; Husebye et al. 2006).  The dependency of signaling on trafficking 
is disputed (Latz et al. 2002; Cuschieri 2004).  Disruption of the Golgi apparatus had no effect 
on LPS induced NF-κB activation but blocked LPS induced IL-8 production (Latz et al. 2002).  
However, disruption of lipid rafts attenuated LPS induced production of TNFα but increased 
production of IL-10 leading to an anti-inflammatory phenotype (Cuschieri 2004).   
The knowledge of intracellular trafficking of glucan and Dectin-1 is limited.  For many 
years it has been assumed that glucans were internalized into endosomes and transported to 
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lysosomes where they were degraded.  These studies were performed prior to the discovery of 
lipid raft mediated internalization and were done using electron microscopy.  The glucan 
containing vesicles were assumed to be endosomes and lysosomes based upon their structure.  
More recent studies have found that upon binding glucan, the Dectin-1/glucan is rapidly 
internalized and trafficked to an unknown organelle (Herre et al. 2004).  Additionally, the fate of 
the Dectin-1 was dependent on the activity of the glucan (Herre et al. 2004).  Binding of the 
biologically inactive glucan laminarin resulted in recycling of Dectin-1 to the cell surface, while 
binding of GP, which is known to have immunomodulatory properties, resulted in Dectin-1 
degradation (Herre et al. 2004).  Studies by McCann et al. found that particulate glucans are 
internalized by a non-caveolin dependent mechanism into endosomes and are trafficked to 
lysosomes (McCann et al. 2005).  This study also demonstrated that cell stimulation was not 
dependent on glucan internalization (McCann et al. 2005).  These authors did not determine the 
means of internalization, nor did they investigate trafficking of soluble glucans.  Furthermore, 
the use of fluorescence microscopy rather than confocal microscopy diminishes confidence in 
these data.  Finally, studies by Karinaga et al. demonstrated that PEG-appended schizophyllan 
could be used to deliver oligonucleotides into cells and avoid lysosomal degradation (Karinaga 
et al. 2005).  Therefore, a more complete study is required to address trafficking by the Dectin-
1/glucan complex.  
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Chemical Mediators of the Immune Response
 Cytokines. Cytokines are soluble chemical mediators of the immune response.  They are 
produced by both classic immune cells and cells that are not considered to be part of the immune 
system.  There are hundreds of different cytokines, and most cytokines had a myriad of different 
effects.  For clarification cytokines can be sub-divided into different types based upon their 
activities.  The pro-inflammatory cytokines tend to stimulate the immune response by activating 
immune cells.  This group includes TNFα, IL-1β, and IL-2 (http://www.copewithcytokines.de).  
Anti-inflammatory cytokines tend to blunt the immune response by inhibiting the production of 
pro-inflammatory cytokines and preventing activation of immune cells.  This group includes IL-
10 as well as the IL-1 receptor antagonist (ra) and the soluble receptor for TNFα 
(http://www.copewithcytokines.de).  Cytokines may also be grouped based upon the type of 
adaptive immune response they induce.  The Th1 cytokines stimulate a cell mediated immune 
response and are represented by interferon (IFN) γ (http://www.copewithcytokines.de).  IL-12 
and IL-18, which stimulate the production of IFNγ, are also considered to be in this group 
(http://www.copewithcytokines.de).  The Th2 cytokines stimulate the humoral or antibody 
mediated immune response.  These cytokines also inhibit the cell mediated immune response and 
include IL-4 and IL-5 (http://www.copewithcytokines.de).  IL-6 is an important cytokine that is 
not easily grouped.  It is primarily an inflammatory cytokine as it activates macrophages and 
neutrophils, but it also stimulates the production of anti-inflammatory mediators 
(http://www.copewithcytokines.de).  Immune cell growth factors are also considered cytokines.  
These mediators stimulate the production of immune cells in the bone marrow.  This group 
includes GM-CSF and G-CSF (http://www.copewithcytokines.de). 
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 Chemokines.  Chemokines are molecules that stimulate cells to migrate to areas of 
inflammation.  Many of these molecules also act as cytokines in that they will activate the cells 
that they attract.  Chemokines have been discovered for lymphocytes, monocytes, and 
neutrophils.  Many of these chemokines will attract multiple cells types.  IP-10 and monokine 
induced by IFN (MIG) attract T lymphocytes (http://www.copewithcytokines.de).  Monocyte 
chemoattractant protein (MCP) and macrophage inflammatory protein (MIP) 1α primarily attract 
monocytes and macrophages (http://www.copewithcytokines.de).  IL-8, IL-17, and keratinocyte-
derived chemokine (KC) attract and activate neutrophils (http://www.copewithcytokines.de).   
 
Critical Illness
C. albicans 
C. albicans is a dimorphic fungus that is part of the normal flora of the oropharynx and 
GI tract (Calderone and Fonzi 2001).  C. albicans can cause a wide range of infections from 
superficial mucosal infections in individuals with normal immune function to life threatening 
systemic infections in the critically ill, immunocompromised host (Calderone and Fonzi 2001; 
Sullivan et al. 2004).  C. albicans is the most frequent fungal pathogen in critically ill and/or 
immunocompromised patients (Wilson et al. 2002; Sullivan et al. 2004).  The mortality rate for 
disseminated candidiasis is greater than 35% and has remained steady despite the discovery of 
multiple anti-fungal drugs (Sullivan et al. 2004).  We do not fully understand the cellular and 
molecular changes that occur in the immunocompromised and/or critically ill patient that render 
them susceptible to life threatening fungal infections, but disseminated or systemic C. albicans 
infection is often associated with neutropenia and/or dysfunctional cell mediated immunity 
(Bodey 2000). 
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C. albicans and the Innate Immune Response.  Despite the medical significance of C. 
albicans, there is still much that we do not know about the cellular and molecular mechanisms 
by which C. albicans species and other fungal pathogens interact with and are recognized by the 
innate immune system.  The C. albicans cell wall contains several PAMPs that may be 
recognized by PRRs in the innate immune system, i.e. mannan, phospholipomannan, and glucan 
(Chauhan et al. 2002; Roeder et al. 2004).  PRRs, such as Toll Like Receptor 2 (TLR2) (Jouault 
et al. 2003; Roeder et al. 2004), TLR4 ( Tada et al. 2002; Roeder et al. 2004), DC-SIGN (Cambi 
et al. 2003) the Type 3 complement receptor (CR3) (Forsyth et al. 1998) and the mannose 
receptor (Allavena et al. 2004), have been reported to be involved in recognition and response to 
these fungal cell wall PAMPs, but the role of these receptors in the response to C. albicans 
infection has been disputed (Bellocchio et al. 2004; Netea et al. 2004).  For example, TLR2, 
which binds phospholipomannan (Jouault et al. 2003; Roeder et al. 2004) and is involved in the 
response to glucan (Gantner et al. 2003), was thought to be essential for protection against fungal 
infection (Villamon et al. 2004).  However, recent studies have shown that TLR2 does not 
protect mice from disseminated candidiasis (Bellocchio et al. 2004; Netea et al. 2004).  Indeed, 
genetic depletion of TLR2 improves survival outcome in candidiasis (Bellocchio et al. 2004; 
Netea et al. 2004).  Additionally, Lee et al. have reported that mannose receptor knock-out mice 
were no more susceptible to disseminated candidiasis than wild type (Lee et al. 2003).  Thus, the 
question of which receptor(s) in the innate immune system are necessary for defense against C. 
albicans remains unanswered. 
Neutrophils are integral to the innate immune response to C. albicans infection (Kullberg 
et al. 1999), and cytokines and chemokines are necessary to activate and attract neutrophils to 
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areas of infection.  Mice infected with C. albicans have increased circulating levels of TNFα, 
IL-6, and IL-17 (Steinshamn and Waage 1992; Huang et al. 2004).  Studies using knock-out 
mice have revealed that loss of TNFα or IL-6 significantly increases susceptibility of mice to C. 
albicans infection (Romani et al. 1996; Mencacci et al. 1998).   Additionally, IL-17 knock-out 
mice infected with C. albicans have a reduced survival rate when compared to wild type controls 
(Huang et al. 2004).  In the case of both IL-6 and IL-17 depletion, animals had impaired 
neutrophil recruitment and activity (Romani et al. 1996; Huang et al. 2004).  The adaptive cell 
mediated immune response is also necessary to eliminate fungal pathogens.  IFNγ, which 
stimulates a cell mediated adaptive immune response, is thought to play an important role in 
innate host defense against C. albicans infection, as genetic depletion of IFNγ reduces survival 
in mice infected with C. albicans (Balish et al. 1998).  Cytokines that stimulate the production of 
IFNγ, such as IL-12 and IL-18, are also integral to an effective cell mediated immune response to 
C. albicans (Netea et al. 2003; Bjorkbacka et al. 2004).  These studies confirm the complexity of 
an effective immune response against C. albicans. 
 
C. albicans, Glucan, and Dectin-1.  Dectin-1 is thought to be an important sentinel 
receptor for fungal infections, especially C. albicans (Brown et al. 2003).  Dectin-1 has been 
found to bind to C. albicans blastospore cells both as a soluble recombinant protein or expressed 
on the surface of transfected cells (Brown et al. 2003; Gantner et al. 2005).  The interaction of C. 
albicans with cellular Dectin-1 results in internalization of the yeast and production of TNFα 
and reactive oxygen species (Brown et al. 2003; Gantner et al. 2005).  While these in vitro 
studies have demonstrated the relationship between Dectin-1 and C. albicans, there are very little 
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data available on the in vivo role of Dectin-1 in fungal infection.  Studies have shown systemic 
administration of GP increases resistance to C. albicans infection (Williams et al. 1978; 
Williams et al. 1991b).  Specifically, glucan treated mice show decreased renal pathology and 
increased survival outcome in response to C. albicans infection (Williams et al. 1991b).  These 
data indicate that Dectin-1 is involved in the immune response to C. albicans, but the effect of C. 
albicans on Dectin-1 in vivo is unknown. 
 
Polymicrobial Sepsis 
The critically ill patient frequently develops a complex disease spectrum that may include 
systemic inflammatory response syndrome (SIRS), sepsis syndrome and/or septic shock 
(Oberholzer et al. 2001).  These conditions are characterized by fever, tachycardia, tachypnea, 
and shock (Brunn and Platt 2006).  Sepsis generally refers to the patient with an infectious 
etiology, while those with SIRS have no demonstrable infection (Brunn and Platt 2006).  In the 
United States ~750,000 patients/year develop sepsis syndrome (Angus et al. 2001).  Of these 
patients, 51.1% receive intensive care and the overall mortality rate is 28.6% (~215,000 
deaths/year) (Angus et al. 2001). The annual cost of sepsis syndrome is ~$16 billion dollars/year 
(Angus et al. 2001).  At present, we do not understand the cellular and molecular mechanisms 
that are involved in the initiation and propagation of septic injury; nor do we understand the 
physiologic mechanisms that attempt to maintain homeostasis and promote survival in the septic 
patient.  In addition, attempts at developing effective therapies for sepsis syndrome have proven 
to be exceedingly difficult.  Consequently, survival outcome in sepsis syndrome has not 
significantly improved over the last few decades (Oberholzer et al. 2001). 
 
36 
Sepsis, SIRS, and the Innate Immune Response.  Severe injury or infectious challenge 
results in the release of multiple exogenous (PAMPs) and endogenous ligands for PRRs present 
on immune cells (Brunn and Platt 2006).  The interaction of PRRs with their ligands results in 
the release of pro-inflammatory mediators.  The most studied of the PRRs involved in the 
etiology of sepsis and SIRS is TLR4.  LPS, the exogenous ligand for TLR4, is released into the 
circulation by Gram negative bacteria.  Administration of LPS in the absence of infection has 
been used as an experimental model of septic shock (Lowry 2005).    TLR4 also has several 
endogenous ligands including the extra-cellular matrix protein heparan sulfate (Johnson et al. 
2002).  These ligands are be released into the systemic circulation by proteases activated by 
trauma or local inflammation (Johnson et al. 2002; Brunn and Platt 2006).  Localized release of 
these ligands results in a localized immune response, but if the amount of ligand is great enough, 
it may be released into the systemic circulation.  The innate immune system may respond by 
over-expressing inflammatory mediators resulting in a systemic inflammatory response that 
culminates in severe shock, multi-organ failure, and death (Oberholzer et al. 2001).   
Cytokines are believed to be intimately involved in the pathogenesis of sepsis, though 
their exact role is not known.  It has been demonstrated that sepsis increases the circulating 
levels of the inflammatory cytokines TNF α and IL-6, and sustained elevations of these 
cytokines correlates with severity of illness and mortality (Damas et al. 1992; Pinsky et al. 
1993).  Additionally, administration of TNFα or IL-1 to rodents and rabbits yields a condition 
that mimics sepsis (Tracey et al. 1986; Bauss et al. 1987; Okusawa et al. 1988).  These studies 
suggest that the inflammatory cytokines are the primary mediators of sepsis; however, inhibition 
of TNFα and IL-1 was found to be protective only in animal models of sepsis while having no 
effect in human patients (Beutler et al. 1985; Ohlsson et al. 1990; Opal et al. 1997; Clark et al. 
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1998).  Further complicating the issue is the role of anti-inflammatory cytokines and soluble 
inflammatory cytokine inhibitors.  Elevated levels of IL-10, IL-1ra, and the soluble receptor for 
TNFα have been found in patients with severe sepsis (Marchant et al. 1994; Neidhardt et al. 
1997; Gogos et al. 2000).  This elevation contributes to the compensatory anti-inflammatory 
response syndrome thought to follow the SIRS in cases of severe sepsis (Bone et al. 1997).  How 
the interaction of pro-inflammatory and anti-inflammatory cytokines relates to sepsis and 
survival in sepsis is not understood. 
 
Sepsis, Glucan, and Dectin-1.  As previously mentioned, administration of GP improves 
survival rates in CLP induced polymicrobial sepsis.  The molecular mechanisms responsible for 
protection are not fully known, but glucan ligands blunt the early increase in tissue transcription 
factor activation, thereby limiting the host pro-inflammatory response to the septic injury 
(Williams et al. 1999b).  Preventing early activation of nuclear factor (NF)-κB and NF-IL6 
positively correlated with improved long-term survival (Williams et al. 1999b). Additionally, 
glucan administration stimulated the phosphoinositide 3 kinase (PI3K) signaling pathway, which 
correlated with improved outcome in CLP sepsis (Williams et al. 2004a).  PI3K has been shown 
to mediate a diverse array of effects and has been speculated to be a negative feedback 
mechanism for innate immune responses (Guha and Mackman 2002; Fukao and Koyasu 2003). 
Blockade of the PI3K pathway with wortmannin completely eliminated the protective effect of 
glucan in sepsis, thus demonstrating that the effect is mediated through a PI3K dependent 
mechanism (Figure 9) (Williams et al. 2004a).  As the induction of a response to glucan begins 
with binding of glucan to PRRs on the cell surface, it is highly likely that Dectin-1 is involved in 
the pathogenesis of sepsis.  Additionally, septic patients have elevated levels of circulating 
A. B. 
Figure 9  Inhibition of PI3K increases abrogates the protection induced by glucan phosphate 
administration mice polymicrobial sepsis  Administration of the PI3K inhibitor wortmannin 
increases mortality in CLP (A).  Glucan induced protection in CLP is lost with wortmannin 
treatment (B) (Adapted from Williams et al. 2004a). 
glucans (Digby et al. 2003).    How Dectin-1 may be affected by circulating glucans in sepsis or 
by administration of glucans in sepsis has yet to be determined. 
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CHAPTER 2 
 
EXPERIMENTAL APPROACH 
 
 An appropriate innate immune response is integral to survival in trauma and infection.  
Binding of PAMPs to PRRs and the cell signaling resulting from this interaction are the first 
steps in the generation of the innate immune response.  Though much has been discovered 
regarding the signaling pathways resulting from the interaction of some PRRs with their PAMPs, 
a complete understanding of how these pathways generate an appropriate immune response has 
not been achieved.  Additionally, the mechanisms that result in an inappropriate response have 
not been determined.  The reasons for this lack of understanding are because of the extreme 
complexity of the innate immune system.  Over time more cell types have been found to be 
involved in innate immunity, and additional PRRs continue to be discovered.  Additional 
signaling pathways used by PRRs also continue to be elucidated, as do the ligands bound by 
PRRs.  Finally, the effects of the innate immune response on the adaptive immune response are 
only now coming to light. 
The majority of information about PRRs has been discovered studying the TLR family of 
receptors.  However, other PRRs do exist and may be as important as the TLRs with regards to 
innate immunity.  Dectin-1 is a newly discovered PRR.  Studies have shown that Dectin-1 is a 
major PRR for the fungal PAMP, glucan (Brown and Gordon 2001; Willment et al. 2001; Brown 
et al. 2002; Taylor et al. 2002; Brown et al. 2003).  As it mediates an inflammatory response 
when bound to glucan as a single molecule or present in the fungal cell wall, Dectin-1 has been 
proposed to be a sentinel receptor for fungal infection (Brown et al. 2003).  However, the studies 
investigating the interaction between Dectin-1 and fungi have been performed in vitro; therefore, 
little is known about the effect of C. albicans infection on Dectin-1 in vivo.  As the ligand for 
Dectin-1 improves survival in polymicrobial sepsis, it is possible that Dectin-1 also plays a role 
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in the pathophysiology of polymicrobial sepsis (Williams et al. 1999b; Williams et al. 2004a).  
Though previous studies have determined that the Dectin-1 ligand GP is blunting the pro-
inflammatory NF-κB pathway and stimulating the anti-apoptotic PI3K pathway in polymicrobial 
sepsis, the role of Dectin-1 in these activities is has not been discovered (Williams et al. 1999b; 
Thomas et al. 2003).  Additionally, elevated levels of circulating glucans have been found in the 
critically ill, regardless of the presence of fungal or bacterial infection (Digby et al. 2003).  It is 
likely that these glucans are interacting with Dectin-1 on innate immune cells.  The 
consequences of this interaction are unknown.  In vivo studies investigating the effects of fungal 
and polymicrobial sepses on Dectin-1 are necessary to begin to address the role of Dectin-1 in 
critical illness. 
Little is known about the effects of the administration of glucan on Dectin-1 in vivo, as 
the majority of studies investigating this interaction have also been performed in vitro (Brown et 
al. 2002; Taylor et al. 2002; Brown et al. 2003; Gantner et al. 2003; Gantner et al. 2005; 
Underhill et al. 2005).  The in vitro studies have used single cell conditions, and frequently the 
cells used are transfected cell lines.  It is possible that these results will not translate in the much 
more complex in vivo milieu.  Additionally, these studies were performed primarily using the 
glucan-containing particle, zymosan (Brown et al. 2002; Taylor et al. 2002; Brown et al. 2003; 
Gantner et al. 2003).  Zymosan is a product of the S. cerevisiae cell wall.  It contains a large 
amount of glucan but is contaminated with other cell wall molecules including mannan.  
Therefore, the effects seen with zymosan are not necessarily attributable to glucan alone.  This is 
supported by the fact that pure glucans such as GP do not have the same effects as zymosan and, 
in many cases, have been used to block the effects of zymosan (Brown et al. 2003).  It has even 
been suggested that GP is actually a Dectin-1 antagonist; however, this is unlikely as GP is a 
potent immunomodulator in vivo.  Studies regarding the in vivo effects of GP on Dectin-1 will 
clarify this issue. 
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Dectin-1 is known to mediate the internalization of glucan (Brown et al. 2002; Herre et 
al. 2004).  The mechanism for this internalization has not been determined, though blockade of 
caveolin-1 does not inhibit glucan uptake (McCann et al. 2005).  Furthermore, trafficking of the 
Dectin-1/glucan complex is poorly understood and may relate to in vivo glucan activity (Herre et 
al. 2004).  Glucans that have biologic activity result in degradation of Dectin-1 upon 
internalization of the Dectin-1/glucan complex, and the receptors remain lost from the surface 
until new receptors have been synthesized (Herre et al. 2004).  Though Dectin-1 mediated 
signaling has been reported to be independent of internalization, it is possible that differences in 
trafficking are responsible for differences in biologic activity (Brown et al. 2003; Herre et al. 
2004; McCann et al. 2005).  Therefore definitive studies are needed to elucidate the mechanisms 
for internalization of the Dectin-1/glucan complex, and to determine how glucans are trafficked 
upon internalization. 
Based upon previous studies regarding Dectin-1 and glucans, we have formed the 
following hypotheses. 
 1. Fungal sepsis will alter Dectin-1 expression in vivo. 
 2. Polymicrobial sepsis will alter Dectin-1 expression in vivo. 
3. Biologically active glucans will alter Dectin-1 expression in vivo, while inactive 
glucans will not. 
 4.  Biologically active glucans will be trafficked differently than inactive glucans. 
  
These hypotheses will be tested in the following 4 specific aims. 
Specific Aim 1:  Determine the effect of systemic fungal infection on Dectin-1 in vivo. 
Specific Aim 2:  Determine the effect of polymicrobial sepsis on Dectin-1 in vivo. 
Specific Aim 3:  Determine the effect of the administration of glucans, active and 
inactive, on Dectin-1 in vivo. 
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Specific Aim 4:  Determine how glucans, active and inactive, are trafficked within the 
cell. 
 
Experimental Design 
 
Specific Aim 1.  Determine the effect of systemic fungal infection on Dectin-1 in vivo. 
Mice will be injected with C. albicans, a clinically relevant fungal pathogen.  Mice 
injected with an equal volume of diluent will be used as controls.  One group will be followed 
for survival.  The remaining mice will be harvested at appropriate times throughout the course of 
infection.  Dectin-1 expression and cell type will be determined on blood and splenic leukocytes 
by flow cytometry.  Dectin-1 expression will be determined in the kidney by 
immunohistochemistry.  Blood, kidney, and lung will be cultured for C. albicans.  Circulating 
cytokine and chemokine concentrations will be determined by Luminex. 
 
Specific Aim 2.  Determine the effect of polymicrobial sepsis on Dectin-1 in vivo. 
Mice will undergo CLP to induce polymicrobial sepsis.  No surgery mice will act as 
normal control, and mice that have had laparotomy only will serve as anesthesia and surgery 
controls.  Half of each group will receive GP (1 mg/mouse) 1 h prior to surgery.  One group will 
be followed for survival.  The remaining mice will be harvested at appropriate time intervals 
throughout the course of infection.  Dectin-1 expression and cell type will be determined on 
blood, peritoneal. and splenic leukocytes by flow cytometry.  Circulating cytokine 
concentrations will be determined by Luminex. 
 
Specific Aim 3.  Determine the effect of the administration of glucans, active and 
inactive, on Dectin-1 in vivo. 
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Mice will be injected with 1 mg/mouse GP, laminarin, mannan, or pullulan.  Control 
animals will receive an equal volume of diluent.  Mice will be harvested at regular intervals over 
the course of 10 d.  Dectin-1 expression and cell type will be determined on blood, peritoneal, 
and splenic leukocytes by flow cytometry.  Circulating cytokine and chemokine concentrations 
will be determined by Luminex. A subset of mice will receive 5 mg/mouse fluorescent labeled 
GP.  Blood and peritoneal leukocytes will be evaluated by confocal microscopy and flow 
cytometry for GP uptake. 
 
Specific Aim 4.  Determine how glucans, active and inactive, are trafficked within the 
cell. 
Macrophages will be harvested from mouse peritoneal cavities after stimulation with 
thioglycollate.  Cells will be treated with fluorescent labeled GP, laminarin, or particulate 
glucan.  A subset of cells will be treated with clathrin or lipid raft internalization inhibitors.  
Cells cultured in 6 well plates will be evaluated for Dectin-1 and glucan internalization by flow 
cytometry after 3 h incubation with glucan.  Cells cultured on 4 chamber slides will be fixed and 
permeablized after varying incubation times with glucan.  The cells will be stained with 
fluorescent labeled antibodies against caveolin-1, clathrin, rab5, GM130, lamp1, GRP78, Dectin-
1, the p85 subunit of PI3K, SR-A, or TLR2.  The cells will be imaged by confocal microscopy 
and analyzed for glucan co-localization. 
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CHAPTER 3 
 
METHODOLOGY 
 
Animals
Age- and weight-matched adult male ICR/HSD mice were obtained from Harlan Sprague 
Dawley (Indianapolis, IN).  Caveolin-1 deficient mice (Cav-/-) and their wild type (WT) control 
(B6129SF2/J) were obtained from The Jackson Laboratory (Bar Harbor, ME).  The animals were 
maintained on standard laboratory chow and water ad libitum with a 12-hour light/dark cycle.  
Serologic testing confirmed that the mice were virus free prior to study entry.  All animal 
procedures were reviewed and approved by the University Committee on Animal Care at the 
James H. Quillen College of Medicine, East Tennessee State University. 
 
Cell Culture
 Elicited macrophages were harvested by peritoneal lavage 72 h after IP injection of 
thioglycollate (2 ml).  Elicited neutrophils were harvested by peritoneal lavage 18 h after IP 
injection of thioglycollate.  Both cell types were maintained in RPMI-1640 medium (Sigma, St 
Louis, MO) supplemented with 10% fetal calf serum (FCS), penicillin, and streptomycin. 
Macrophages were allowed to adhere overnight prior to treatment, and neutrophils were treated 
just after harvest. 
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Candida albicans
A laboratory strain of C. albicans was used that produced true germ tubes within 2 h 
when incubated at 37ºC in FCS.  The strain is a human vaginal isolate that has been used as a 
laboratory control strain since the early 1980s.  No information on the effects of this strain was 
available in mice.  A blood agar plate (BAP) was streaked with a control culture of C. albicans 
and incubated at 37ºC for 48 h.  A 5 ml tube of Brain Heart Infusion (BHI) broth (Difco 
Laboratories, Detroit, MI) was inoculated with 1 colony of C. albicans and incubated at 37ºC in 
a slanted position with agitation at 200 rpm for 18 h for production of a maximal biomass of 
blastospores.  The blastospores were washed 3 times with sterile physiologic saline by 
centrifugation and suspended to 5 ml.  A viable count was determined by serial 10-fold dilutions 
in saline and triplicate plating of 1 µl of each dilution on BAP.  The stock was suspended in 5% 
dextrose in water to produce a final concentration of 5x105 cfu/ml. 
 
Carbohydrates 
Water soluble Saccharomyces cerevisiae derived glucan phosphate (GP) was prepared 
and chemically characterized as previously described (Williams et al. 1991a; Ensley et al. 1994; 
Mueller et al. 1994; Mueller et al. 1995; Lowman et al. 1998).  The final product was stored (-
80oC) as a lyophilized powder.  It was dissolved in dextrose 5% w/v (D5W, Baxter, Toronto, 
Canada), filter sterilized (0.45 µm), and screened for endotoxin contamination with the 
Endospecy assay (Seikagaku, Tokyo), which is specific for endotoxin but does not respond to 
(1→3)-β-D-glucans (Kambayashi et al. 1991; Miyazaki et al. 1995).  Laminarin (Sigma, St. 
Louis, MO), a biologically inactive (1→3)-β-D-glucan, was used to further investigate the role 
of Dectin-1.  Mannan (Sigma, St. Louis, MO) and pullulan (Pfanstiehl, Waukegan, IL) were used 
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as control carbohydrates as they are known to not interact with Dectin-1. The carbohydrates 
were dissolved in D5W, incubated overnight in pre-washed polymyxin coated agarose beads 
(BioRad, Hercules, CA) to remove endotoxin, and filter sterilized prior to use.  Diaminopropane 
derivatized GP, laminarin, and particulate glucan (Kougias et al. 2001) were labeled with Alexa 
Fluor 488 (AF488) or AF647 (Molecular Probes, Eugene, OR) by hydrating the glucan in 0.1 M 
borate buffer, pH 8.5, dissolving the succidamidyl ester form of AF488 or AF647 in DMSO to a 
concentration of 100ug/ml, and incubating the 2 in the dark overnight with rotation at ambient 
temperature.  Excess dye was removed by dialysis against water until dye was no longer visible 
in the dialysate.  The labeled product was then buffer exchanged into D5W.  Conjugation and 
binding activity were confirmed by incubation of the labeled glucan with Dectin-1 transfected 
cells for 30m at 4ºC, washing 3 times with phosphate buffered saline (PBS) and analyzing by 
flow cytometry. 
 
Polymicrobial Sepsis 
 Cecal ligation and puncture was performed to induce polymicrobial sepsis (Baker et al. 
1983; Williams et al. 1999a; Yang et al. 2002;).  Briefly, mice were anesthetized with isoflurane, 
and a ventral midline incision was made.  The cecum was externalized and the cecal contents 
were milked to the distal end of the cecum.  The cecum was ligated with 0 silk suture distal to 
the ileocecal junction and two punctures were made in non-vascular areas with an 18g needle.  A 
small amount of ingesta was extruded from the punctures, the cecum was returned to the 
abdominal cavity, and the wound was closed in 2 layers.  The mice were recovered with 1 ml 
lactated ringers solution subcutaneously.  Sham surgery (laparotomy alone) mice were used as a 
control for surgery and anesthesia, and animals that underwent no surgery or anesthesia were 
used as negative controls. 
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In Vivo Experimental Protocols
C. albicans Infection.  Mice were administered 1 x 105 C. albicans IV.  Control mice 
received diluent IV.   Spleens and blood were harvested at 1, 3, 5, and 7 days post-injection for 
flow analysis.  Kidney, lung, and blood were also harvested for culture, and serum was harvested 
for cytokine concentration.  Kidneys were harvested for immunohistochemistry.  A parallel 
group of mice were administered 1 x 105 C. albicans cells IV and survival was followed for up to 
21 days.   
  
Polymicrobial Sepsis.  One hour prior to surgery, mice were administered 1 mg GP or an 
equal volume of 5% Dextrose in water IP.   The treatment groups were: i) no surgery (control), 
ii) sham surgery (laparotomy only), iii) cecal ligation and puncture (CLP), iv) glucan without 
surgery, v) sham surgery + glucan, vi) CLP + glucan.  Mice were sacrificed at 0, 3, 6, 12, and 
24h post-operatively and peritoneal cells, splenocytes and peripheral blood leukocytes were 
obtained for flow cytometric analysis.  Serum was harvested at 12 h post-operatively for 
cytokine analysis.  Parallel groups of untreated and glucan treated CLP mice were monitored for 
survival for 14 d.  
 
 Glucan Injection.  At time 0 mice were given either 1 mg GP, 1 or 5 mg AF488-GP, 1 mg 
laminarin, 1 mg mannan, 1 mg pullulan, or an equal volume of D5W intravenously (IV) or 
intraperitoneally (IP).   Mice were sacrificed at 0 h, 3 h, 1, 3, 5, 7, and 10 d post-injection and 
peritoneal cells, bone marrow cells, splenocytes, and peripheral blood leukocytes were obtained 
for flow cytometry or confocal microscopy.  Serum was collected at 0, 3, 24, and 72 h post-IV 
injection for cytokine analysis. 
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In Vitro Experimental Protocols 
 
Dectin-1 Internalization Studies.  Thioglycollate elicited neutrophils were cultured in 12 
well plates (Corning Incorporated, Corning, NY) at 500,000 cells/well.  The cells were incubated 
with 1 µg/ml S. cerevisiae derived GP, C. albicans blastospore derived GP, C. albicans hyphal 
derived GP, S. cerevisiae derived mannan (Sigma), or E. coli O55:B5 LPS (Sigma) alone or in 
combination for 3 h. 
 
Internalization Inhibitors.  Thioglycollate elicited macrophages from ICR/HSD mice, 
Cav-/- mice or WT mice were cultured in 6 well plates (Corning Incorporated) at 750,000 
cells/well and allowed to adhere overnight.  The cells were incubated with 10 µg/ml fluorescent 
labeled GP for 3 h.  Cells were incubated with either media alone, 5 mM methyl β cyclodextran 
(MβCD, Sigma) to disrupt lipid rafts, or 500 mM sucrose (Fisher Scientific, Fair Lawn, NJ) to 
inhibit clathrin polymerization for 1 h prior to addition of the GP.  
 
Flow Cytometry 
Peritoneal cells were obtained by peritoneal lavage.  Bone marrow cells were obtained by 
flushing the femoral marrow cavities with sterile PBS.  Splenocytes were isolated by teasing 
apart the spleens and separation of the splenic stroma by sedimentation.  Whole blood was 
collected into EDTA Microtainer tubes (Becton Dickenson Vacutainer Systems, Franklin Lakes, 
NJ).  Red blood cells were lysed in all samples using PharmLyse buffer (Pharmingen) according 
to the manufacturer’s directions. Cultured macrophages were scraped into Pharmingen stain 
buffer, and non-adherent cultured neutrophils were harvested and then washed with stain buffer. 
Cells were blocked with 5% rabbit serum, 0.5% bovine serum albumin, and 5 mM EDTA with 
anti-murine CD16/32 (Pharmingen) prior to staining.  Staining was performed according to 
Becton Dickenson protocols at 4°C.  Cells were stained with biotin conjugated rat anti-murine 
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Dectin-1 (2a11) (Brown et al. 2003), biotin conjugated goat anti-murine Dectin-1 (R and D 
Systems, Minneapolis, MN), Fluorescein isothiocyanate conjugated anti-neutrophil (clone 7/4) 
(Serotec Oxford, UK), Allophycocyanin conjugated anti-F4/80 (Caltag, Burlingame, CA), and 
Peridinin chlorophyll-A protein conjugated anti-CD3 (Pharmingen, San Diego, CA) or their 
isotype control antibodies.  Biotinylated antibodies were detected by streptavidin-phycoerythrin 
(Pharmingen).   Cells were suspended in Pharmingen Stain Buffer and analyzed using a 
FACScalibur flow cytometer with CellQuest software (BD Biosciences, Mountain View, CA).   
 
Cytokine and Chemokine Analysis 
Blood was collected into serum separator Microtainer tubes (Becton Dickenson 
Vacutainer Systems), spun at 2000 rpm, and the serum was harvested and stored at -80ºC until 
analysis.  Serum samples were diluted 1:2 with PBS prior to assay.  The assay was performed 
using the Biosource Mouse Multiplex 10 cytokine kit (Camarillo, CA) that includes tumor 
necrosis factor alpha (TNFα), interleukin (IL)-1 beta, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, 
interferon gamma (IFNγ), and granulocyte monocyte colony stimulating factor (GM-CSF) with 
an additional 6 chemokines (cytokine-induced neutrophil chemoattractant (KC), interleukin (IL)-
17, inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, macrophage 
inflammatory protein (MIP)-1α, and monokine induced by gamma interferon (MIG)) according 
to manufacturer’s instructions.  The samples were analyzed on a Luminex 100 (Austin, TX). 
Cytokine concentrations were established with MasterPlex QT software v. 1.2.8.58 (MiraiBio, 
Inc. Alameda, CA). 
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Blood and Tissue Culture of C. albicans 
Spleen, kidney, lung, and blood were collected by aseptic surgical procedures.  Blood 
(250µl) was incubated 1 week in brain heart infusion broth at 30ºC. The organs were dipped into 
70% ETOH and flamed over a Bunsen burner.  They were placed individually into a sterile 
tissue grinder and homogenized into 1 ml saline.  Two drops from a sterile Pasteur pipette 
(~50µl) of the organ mixture or the blood culture were placed on duplicate blood agar plates and 
streaked for isolation.  After incubation at 30ºC for 48h, the amount of growth was determined 
by counting the largest number of quadrants that contained colonies of C. albicans.  The 
identification of C. albicans was established by Gram stain and germ tube formation in FCS at 
37ºC for 2 h. 
 
Histopathology 
Tissues were collected into 10% buffered neutral formalin (Fisher Scientific, Fair Lawn, 
NJ), paraffin embedded and then sliced into 5 micron sections.  The sections were stained with 
hematoxylin and eosin (H&E) or fungal periodic acid Schiff (PAS) reagent.   
 
Immunohistochemistry
Tissues were collected, embedded in “Tissue-Tek” OCT compound (Miles Inc., Elkhart, 
IL), and snap frozen with isopentane and liquid nitrogen.  The tissues were stored at -80ºC until 
sectioning.  Tissues were sliced into 8 micron sections onto Vectabond (Vector Laboratories, 
Burlingame, CA) treated slides, dried for 10 m, and fixed in 95% ethanol at 4ºC for 10 m.  The 
slides were washed for 5 m in PBS and then blocked for 1 h in 10% normal donkey serum at 
ambient temperature.  The slides were incubated in 2a11, rat anti-F4-80 (Caltag), rat anti-
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neutrophil (Serotec) or isotype control antibodies (10 µg/ml in 1% BSA in PBS) for 1 h at 4ºC 
followed by washing (3x) for 5 m in PBS.  The slides were incubated in AF488 (Molecular 
Probes) or Texas Red (Jackson ImmunoResearch, West Grove, PA) conjugated anti-rat antibody 
(10 µg/ml) and 300 nM DAPI (Molecular Probes) for 1 h at ambient temperature.  The slides 
were washed 2 times for 5 m in PBS, and then once for 5 m in water.  The slides were mounted 
under cover slips with Prolong Anti-Fade (Molecular Probes) and imaged with a fluorescent 
microscope. 
 
Confocal Microscopy 
All slides were evaluated on a Leica DM IRBE inverted confocal microscope with the 
TC2 SP2 microscope system (Leica, Exton, PA). 
 
 In Vivo Internalization Studies.  Resident peritoneal cells, blood, and spleens were 
harvested from mice at 3 and 5 h after injection with AF488 labeled GP.  The cells were 
prepared as described for flow cytometry, except that after lysis of red blood cells the cells were 
fixed in 4% w/v paraformaldehyde (Fisher Scientific) at ambient temperature for 10 m.  The 
cellular nuclei were counterstained by incubating the cells with 1 µg/ml propidium iodide 
(Molecular Probes) for 10 m.  The cells were mounted onto glass slides and cover-slipped using 
Prolong Anti-Fade mounting media (Molecular Probes).  All procedures were performed in the 
dark. 
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In Vitro Co-localization Studies.  Thioglycollate elicited macrophages were cultured in 4 
chamber slides (Lab-Tek, Nalge Nunc International. Naperville, IL) at 100,000 cells per well in 
RPMI-1640 medium supplemented with 10% serum and antibiotics.  The remaining procedures 
were performed in the dark.  Cells were incubated with 100 µg/ml fluorescent labeled GP, 
laminarin, or particulate GP (AF647) in serum free media at 4○C for 3 hrs, then at 37○C for 5-60 
m.  The slides were washed with PBS, fixed with 4% paraformaldehyde (Fisher Scientific), and 
permeablized with 1% Triton-X100 (Sigma).  The cells were blocked (1 h) with 10% normal 
horse serum and then incubated overnight with goat anti-Dectin-1 antibody (R and D Systems), 
or with 1 of the following antibodies from Santa Cruz Biotechnology (Santa Cruz, CA): goat 
anti-GM130, goat anti-lamp1, goat anti-GRP78, goat anti-TLR2, goat anti-scavenger receptor A, 
rabbit anti-caveolin-1, rabbit anti-clathrin heavy chain, rabbit anti-rab5B, rabbit anti-P85 at 4○C.  
Alternately, cells were stained for lipid rafts using an AF 555 Vybrant Lipid Raft Labeling Kit 
(Molecular Probes) according to manufacturer’s directions.  Following 3 washes with PBS, the 
cells were stained with rhodamine (TRITC) conjugated anti-goat antibody (Jackson 
ImmunoResearch) or AF 546 conjugated anti-rabbit antibody (Molecular Probes) diluted in 
Sytox green nuclear counterstain (Molecular Probes).  The slides were washed in PBS, followed 
by water, and then cover-slips were mounted using Prolong Anti-fade (Molecular Probes).  
Images were evaluated using multicolor/2D cytofluorogram software from Leica Microsystems.  
The software quantifies the extent of co-localization by creation of a binary mask of the image 
data in the cytofluorogram (Figure 10).  The binary mask is created by masking all of the pixels 
that are double positive for both the GP fluorescence and for the organelle or receptor 
fluorescence.  Co-localization was then assessed using the mask intensity rate for the co-
localized GP versus the overall intensities of the GP in the image.  A rate distribution analysis 
was performed for each type of glucan.  Two peaks were noted with each type of glucan and 
were denoted negative and positive for co-localization.  Thus mask intensity rates of > 35% were 
considered positive for co-localization for soluble glucans (Figure 11A) and >20% was 
considered co-localized for particulates (Figure 11B).  
Figure 10  Representative 2-D cytofluorogram  The 
green pixels represent one fluor, i.e.the anti-
organelle antibody, in the image while the red pixels 
represent the other fluor (i.e. fluroescent labeled 
glucan).  The blue pixels represent the co-localized 
fluors.  The mask intensity rate is calculated as the 
glucan pixels in the co-localized area as a 
percentage of all glucan pixels in the image.   
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Figure 11 Frequency of mask intensity rates for soluble (A) and particulate (B) glucans  Mask 
intensity rates were determined for individual glucan containing cells as described.  The values 
were rounded to the nearest 5 (i.e. 5, 10, 15), and the frequency of each value was determined.  
Based on this analysis, a mask intensity rate greater than 35 was determined to be positive for 
co-localization for soluble glucans and greater than 20% was considered positive for 
particulate glucan. 
Statistical Analysis
Percent Dectin-1 positive cells, percent neutrophils, and glucan fluorescence data were 
summarized by the mean and standard error (SEM). Group mean responses were compared by 
analysis of variance and pair-wise multiple comparison testing by the least significant difference 
procedure (or Tukey’s procedure when ANOVA was not significant). Probability levels of 0.05 
or smaller were considered significant. 
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CHAPTER 4 
 
RESULTS 
 
Mortality Trend of Mice Infected with C. albicans
To address Aim 1 a model of systemic fungal infection in mice was required.  C. albicans 
was chosen as it is the most common opportunistic fungal pathogen (Wilson et al. 2002; Sullivan 
et al. 2004). The strain of C. albicans used in this study is a human vaginal isolate that has been 
used as a laboratory control strain since the early 1980s.  No information on the effects of this 
strain was available in mice.  To establish the appropriate challenge dose, groups of mice were 
injected IV with C. albicans blastospores over a dose range of 1x105 to 1x107 cfu/mouse.   Doses 
above 1x105 cfu/mouse resulted in rapid mortality, usually within 2-3 days (data not shown).  
Extensive survival analysis using 1x105 cfu/mouse of C. albicans was then performed.  
Intravenous injection of 1x105 cfu/mouse of C. albicans resulted in a median survival time 
(MST) of 13 days and time to 100% mortality of 21 days (Figure 12).  Based on the survival 
kinetics, samples were collected on days 1, 3, 5, 7, and 14 of infection (Figure 12, arrows). 
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Figure 12 Mortality trend for C. albicans infection  Mice were 
injected at time 0 with 1x105 cfu C. albicans, IV.  The first 
death was recorded on day 6. The median survival time was 13 
days and time to 100% mortality was 21 days.  Arrows 
indicate the time intervals at which samples were harvested.  
N=10. 
 
Increased Dectin-1 Expression in C. albicans Infection is Primarily Because of Increased 
Recruitment of Dectin-1 Positive Cells into the Blood and Spleen 
Previous studies regarding the interaction of C. albicans and Dectin-1 have been 
performed in vitro (Brown and Gordon 2001; Brown et al. 2003; Gantner et al. 2005).  Thus the 
effects of systemic infection with C. albicans on Dectin-1 in vivo have not been determined.  
Dectin-1 expression on blood and splenic leukocytes from C. albicans infected and control mice 
were compared by flow cytometry.   Overall, the percentage of Dectin-1 positive cells was 
increased in both blood and splenic leukocytes from C. albicans infected mice when compared to 
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non-infected controls (Figures 13A and B).  Increases of 44.0%, 23.5%, and 58.9% (p<0.05) 
were observed in the percentage of Dectin-1 positive blood leukocytes on days 3, 5, and 14, 
respectively (Figure 13C).  The percentage of Dectin-1 expressing splenic leukocytes showed an 
86.5% (p<0.05) increase at day 7 post-infection (Figure 13D).  The increase seemed to be 
biphasic with peaks at 3 and 7 days.   Dectin-1 expression has been reported to vary among the 
Figure 13   Infection with C. albicans increases Dectin-1 positive cells in the blood and spleen  
Mice were injected at time 0 with 1 x 105 cfu C. albicans, IV.  Blood (A and C) and spleen (B 
and D) cells were harvested and stained with anti-Dectin-1 antibody (2a11) prior to flow 
cytometric analysis.  A and B.  Representative histograms of 3 and 7 d data, respectively.  C 
and D.  The data were normalized to the unchallenged control group, which was set at 1. 
N=3/group/time interval. values are means ± SEM, * indicates p<0.05 compared to control at 
each time point. 
C. D.
Dectin-1 Fluorescence 
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different leukocyte cell types (Willment et al. 2001; Brown et al. 2002; Taylor et al. 2002). 
Therefore, 4 color flow analysis was performed to determine cell type and Dectin-1 expression in 
order to determine whether the increases in Dectin-1 expression were because of changes in 
cellular population dynamics or because of changes in Dectin-1 surface expression on individual 
cells.  C. albicans infection increased the percentage of neutrophils and decreased the percentage 
of T lymphocytes in both the blood and the spleen (Figure 14).  In the blood the percentage of 
neutrophils was significantly increased by 107.3%, 98.3%, and 76.2% at 3, 5, and 14 days, 
respectively (Figure 14A).  The percentage of splenic neutrophils was increased by 353% and 
215.9% (p<0.05) at 7 and 14 days, respectively (Figure 14B).  In the blood the percentage of 
monocytes was increased on day 3 post-infection (data not shown).  Conversely, the percentage 
of T lymphocytes was decreased in both the blood (Figure 14C) and in the spleen (Figure 14D), 
when compared to non-infected control mice.  A decrease of 37.9%, 34.0%, and 65.7% (p<0.05) 
in the percentage of blood T cells was observed on days 3, 5, and 7 post-infection, respectively 
(Figure 14C).   The percentage of splenic T cells was decreased by 35.0% (p<0.05) on day 14 
post-infection (Figure 14D).   
 
The Overall Amount of Dectin-1 Expressed by Neutrophils is Decreased, but the Percentage of 
Dectin-1 Positive T Cells is Increased, in Response to Systemic Candidiasis
Neutrophils are felt to be the first line of defense against C. albicans (Romani 2004) and 
express high levels of Dectin-1 on their surface (Taylor et al. 2002).  However, infection with C. 
albicans resulted in a decrease in the amount of Dectin-1 expressed on the surface of both blood 
and splenic neutrophils (Figures 15A and B), though the percentage of Dectin-1 positive
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Figure 14 C. albicans infection increases the percentage of blood and splenic neutrophils and a 
decrease in blood and splenic T lymphocytes  Mice were injected at time 0 with 1 x 105 cfu C. 
albicans, IV.  Blood leukocytes (A and C) and splenocytes (B and D) were harvested and 
stained with anti-neutrophil (A and B) and anti-T lymphocyte (C and D) antibodies, prior to 
flow cytometric analysis.  The data were normalized to the unchallenged control group, which 
was set at 1. N=3/group/time interval. Values are means ± SEM, *indicates p<0.05 compared 
to control at each time point. 
 
neutrophils remained unchanged (data not shown).  On days 7 and 14 post-infection, Dectin-1 
mean fluorescence on blood neutrophils was decreased by 52.61 and 50.23%, respectively 
(p<0.05) (Figure 15A).  Splenic neutrophils also showed decreased Dectin-1 mean fluorescence 
that was significant on days 3 and 7 post-infection (48.96 and 53.28%, respectively, p<0.05) 
(Figure 15B).  Typically, T cells have been found to express Dectin-1 at low levels, if at all 
(Taylor et al. 2002).  While overall the percentage of T cells in the spleen decreased in response 
to candidiasis, the remaining T cells showed an increased percentage of Dectin-1 positive cells 
on days 3 (36.6%) and 7 (23.3%) when compared to control mice (p<0.05) (Figure 15C).  Thus, 
the increase in Dectin-1 positive cells in the blood and spleen of mice with candidiasis is 
primarily because of an increased recruitment of Dectin-1 positive neutrophils to the periphery, 
although there was a decrease in neutrophil Dectin-1 surface expression.   In contrast, we 
observed a decrease in the percentage of T cells, but the percentage of those T cells that were 
Dectin-1 positive was increased in response to systemic C. albicans infection.    
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Figure 15  Neutrophils expressed less Dectin-1 on their surface with C. albicans infection, 
while an increased percentage of Dectin-1 positive T cells was observed in the spleens of 
mice with C. albicans infection  Mice were injected at time 0 with 1 x 105 cfu C. albicans, 
IV.  Blood leukocytes (A) and splenocytes (B and C) were harvested and stained with anti-
neutrophil (A and B), anti-T lymphocyte (C), and anti-Dectin-1 (2a11) prior to flow 
cytometric analysis. The mean fluorescence for Dectin-1 was determined on the neutrophil 
population and the percent Dectin-1 positive cells was determined in the T lymphocyte 
population.  The data were normalized to the unchallenged control group, which was set at 
1.  N=3/group/time interval. Values are means ± SEM, * indicates p<0.05 compared to 
control at each time point. 
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Dectin-1 Positive Neutrophils and Macrophages are Recruited into C. albicans Induced Renal 
Lesions 
Previous studies have reported that systemic challenge of mice with C. albicans results in 
the development of renal abscesses (Rogers and Balish 1978; Williams et al. 1978).  To confirm 
that the present model of candidiasis was nephrotrophic, disease progression was characterized 
by histopathology and culture of C. albicans in tissues.  Blood, kidney, and lung tissues were 
cultured at 1, 3, 5 and 7 days post-infection.  C. albicans was cultured from all infected mice at 
all time intervals (Table 1).  Blood cultures were positive only on day 1, although large numbers 
of C. albicans were cultured from all kidneys at all time intervals (Table 1).  Lung tissue showed 
sporadic culture positivity. Control tissues were negative for growth at all time intervals (data 
not shown).  The lack of positive blood cultures, despite highly positive cultures from other 
organs, is consistent with findings from patients in which up to 40% of those with wide-spread 
infection are blood culture negative (Bodey 2000).   
 
Table 1 Presence of viable C. albicans in blood, kidney and lung 
 Day 1 Day 3 Day 5 Day 7 
Blood + + - - - - - - - - - - 
Kidney + + ++ ++ ++ + ++ ++ ++ ++ ++ ++ 
Lung - + + - + - - - - + - - 
 
Tissue cultures were carried out as described.  Each quadrant positive for candidal growth is 
represented by +, whereas, - indicates no growth.  N=3/group/time point. 
 
A. B. 
Figure 16  Systemic infection with C. albicans induces renal abscesses in mice Mice 
were injected on day 0 with 1x105 cfu C. albicans or diluent.  Kidneys were harvested 
on day 3 post-challenge.  H and E (A) staining showed renal lesions surrounded by 
inflammatory infiltrate (dark blue, 100X). Periodic acid Schiff staining (B) of a 
consecutive section clearly demonstrates the presence of fungal elements 
characterized by a hyphal mass (red, 100X).  
Renal abscesses were grossly apparent upon necropsy (data not shown). To better 
characterize the colonization of the kidney, sections were fixed and stained by H&E and PAS 
(Figure 16).  H&E sections of kidney show multiple zones of proliferation of C. albicans 
(lavender) with associated inflammatory infiltrate (deep blue) (Figure 16A).  PAS staining better 
illustrates the proliferation of fungal organisms (red) (Figure 16B).  Fungal hyphae were clearly 
evident and foci of candidal proliferation were present in the renal cortex and medulla.  We 
conclude that this strain of C. albicans is nephrotrophic.   
Because the kidneys were the primary organ affected by C. albicans infection, the level 
of Dectin-1 expression in renal foci was determined by performing immunohistochemistry on the 
kidneys from infected and non-infected mice.  As expected, overall Dectin-1 expression (green) 
in the C. albicans infected kidneys was increased in the area of renal lesions (Figure 17B, white 
arrows) when compared to kidneys from normal control mice (Figure 17A).  Dectin-1 expressing 
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cells were found near glomeruli and in the nearby tubular system.  Higher magnification shows 
the Dectin-1 positive cells (Figure 17D, white arrows) associated with foci of fungal elements 
(Figure 17D, arrowhead), while the control kidney shows very little Dectin-1 positivity (Figure 
17C).   Staining of sequential slices for macrophages and neutrophils revealed that the area of 
Dectin-1 positivity was co-localized to an area containing predominantly macrophages (in red) 
(Figure 18A) with fewer neutrophils (in red) (Figure 18B).  Fungal elements are again evident in 
these sections (Figure 18, arrowheads).  Thus, the increased Dectin-1 expression observed in the 
kidneys of mice with candidiasis is because of an influx of Dectin-1 positive macrophages and, 
to a lesser extent, neutrophils in areas immediately adjacent to the candidal elements. 
 
Figure 17   Dectin-1 positive cells are found in association with C. albicans induced renal 
lesions Mice were injected on day 0 with 1 x 105 cfu C. albicans or diluent.  
Immunohistochemistry using anti-Dectin-1 antibody (green) and the DAPI nuclear 
counterstain (blue) showed Dectin-1 positivity (white arrows) in kidneys from Candida 
infected mice (B).  Control kidneys (A) did not show Dectin-1 positivity (100X).  Higher 
magnification (400X) revealed that while the control kidney was not positive (C), in the 
Candida infected kidney, Dectin-1 positive areas (D, white arrows) were associated with 
fungal elements (D, arrowhead). Representative images. 
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Figure 18   Dectin-1 positive macrophages and neutrophils are found in association with C. 
albicans induced renal lesions Mice were injected on day 0 with 1 x 105 cfu C. albicans or 
diluent. Staining of consecutive sections from those in Figure using anti-macrophage or 
neutrophils antibody (red) and the DAPI nuclear counterstain (blue) showed that the Dectin-1 
positive areas predominantly co-localized with macrophages (red) (A) and to a lesser extent 
with neutrophils (red) (B).  These cells are also adjacent to fungal elements (arrowheads).  
400X.   Representative images. 
 
Mortality Trend of Mice With Cecal Ligation and Puncture Induced Polymicrobial Sepsis in the 
Presence and Absence of Glucan Treatment 
 The previous sections determined the effect of fungal infection on Dectin-1 and 
completed Aim 1.  To address Aim 2 the cecal ligation and puncture model of polymicrobial 
sepsis was used.  Previous studies have shown that this model of polymicrobial sepsis generally 
has a survival rate of 20%, while immunoprophylaxis with glucan phosphate will improve 
survival to 80% (Williams et al. 1999b).  To confirm that observation and to determine 
appropriate time intervals for study, ICR/HSD mice were treated with glucan phosphate (40 
mg/kg, IP) 1 hr prior to CLP. A single prophylactic injection resulted in a 70% long-term 
survival rate (p<0.05) (Figure 19).  In contrast, control mice subjected to CLP showed a median 
survival time of ~30 h and a 20% long-term survival (Figure 19).  The first deaths occurred in 
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the control group at ~22 h and in the glucan treated at ~28 h after CLP, respectively. Samples for 
Dectin-1 analysis were harvested at 3, 6, 12, and 24 h after surgery (Figure 19).     
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The Percentage of Dectin-1 Expressing Blood Leukocytes is Decreased by Polymicrobial Sepsis 
and Further Decreased by GP Administration 
 To determine the in vivo effects of polymicrobial sepsis, Dectin-1 expression was 
assessed on blood leukocytes using flow cytometry at 3 and 12h post-CLP.  During the course of 
these experiments, 3 populations of peripheral blood Dectin-1 expressing leukocytes were 
identified in normal mice:  negative for Dectin-1, low level expressers of Dectin-1, and high 
level expressers of Dectin-1 (Figure 20A).  Approximately 60% of the total peripheral 
leukocytes expressed no Dectin-1 (Figure 20A).  The majority of peripheral blood leukocytes 
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Figure 19  Glucan administration improves survival in CLP 
induced sepsis  Mice underwent CLP at time 0.  Glucan 
phosphate (1 mg/mouse) or diluent was administered IP 1 h prior 
to surgery.  Mice were followed for survival to day 14 post-
operatively. N=10/group. 
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from control mice that do express Dectin-1 show high levels of Dectin-1 expression (Dectinhigh) 
(Figure 20).  Following CLP and/or glucan administration there is a dramatic and significant 
shift in Dectin-1 expression levels from the high expression population to the low expression 
population (Figure 20A).  However, Dectin-1 expression is not completely lost from all Dectin-1 
expressing cells in the presence of sepsis, glucan, or a combination of the two.  Therefore, these 
leukocytes have been classified as Dectin-1low, indicating a decrease in Dectin-1 surface 
expression.  For the purposes of this investigation, the data described below focus on the cell 
populations that show a shift from normal levels of expression (Dectin-1high) to decreased 
Dectin-1 expression (Dectin-1low). 
   Flow cytometric analysis revealed that CLP significantly decreases the percentage of 
Dectin-1high expressing cells by 51.4 and 50.9% at 3h when compared to control and sham 
surgery, respectively (Figure 20B, p<0.05).  Dectin-1high expressers returned to baseline by 12 h 
(Figure 20C).  The percentage of Dectin-1low expressing cells was increased by CLP at 3 h post-
operatively when compared to control (145.9%) and to sham (54.5%) (data not shown).  The 
percentage of Dectin-1low positive cells returned to control values by 12 h (data not shown).  
Glucan administration resulted in a significant decrease of 48.5% in the percentage of Dectin-
1high positive leukocytes at 3 h post-CLP when compared to untreated CLP animals (Figure 20B, 
p<0.05).  Dectin-1high expressers in glucan treated mice returned to control values by 12h post 
surgery (Figure 20C).  The percentage of Dectin-1low positive blood leukocytes was increased by 
28.5% at 3 h post-CLP in glucan treated animals when compared to CLP alone (data not shown).  
These cell numbers also returned to normal at 12 h (data not shown). 
Control Glucan Sham Sham +  
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The Percentage of Dectin-1 Positive Splenic Leukocytes was Decreased while the Number of 
 
Dectin-1 Positive Peritoneal Cells was Increased by Polymicrobial Sepsis 
Dectin-1 expression on splenic and peritoneal leukocytes was examined using flow 
cytometry at 0, 3, 6, 12, and 12 h post-CLP.  Splenic leukocytes from CLP animals showed a 
significant decrease in the percentage of Dectin-1 expressing cells (19.6%) when compared to 
Sham, but this decrease was only significant at 12h (Figure 21A, p<0.05).  In glucan treated 
septic mice, the percentage of Dectin-1 expressing cells was significantly decreased in the spleen 
at 6 and 12h post-CLP by 33.9 and 34.1%, respectively when compared to untreated CLP mice 
(Figure 21B, p<0.05).   
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Figure 20  Sepsis decreases Dectin-1 expression on peripheral leukocytes The 
administration of glucan results in a further decrement in leukocyte Dectin-1 positivity.  
Mice underwent no surgery (control), lapartomy (sham) control or CLP at time 0.  Glucan 
phosphate was administered 1 h prior to surgery.  Peripheral leukocytes were isolated and 
assayed for Dectin-1 surface expression at 3 (A and B) and 12 h (C).  A.  Representative 
histogram of 3 h data.  B and C.  Data are normalized to the no surgery control, which was 
set at 1.0. N=3/group, values are means ± SEM.  *p<0.05 compared to control; + p<0.05 
compared to sham surgery and # p<0.05 compared to CLP. 
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Figure 21  Sepsis decreases the percentage of Dectin-1 positive splenocytes, and glucan 
further decreases this percentage  Mice underwent sham or CLP at time 0. Diluent or 
glucan was injected 1 h prior to surgery.  At 0, 3, 6, 12, and 24 h spleens were harvested, 
reduced to single cells, and stained with anti-Dectin-1 antibodies.  Data were normalized to 
0 h means which were set to 1.  N=3/group/time point, values are means ± SEM. *indicates 
p<0.05 compared to sham (A) or to CLP (B). 
The percentage of Dectin-1 positive peritoneal leukocytes from mice that have undergone 
CLP showed a significant 774% increase 12h post-operatively when compared to sham surgery 
mice (Figure 22A, p<0.05).  Glucan treatment with CLP significant decreased the percentage of 
Dectin-1 expressing cells at 3 (89.2%) and 12h (90.1%) when compared to CLP alone (Figure 
22B). 
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Figure 22  Sepsis increases Dectin-1 expressing resident peritoneal cells, while glucan 
administration with sepsis causes a decrease in Dectin-1 positive resident peritoneal cells 
Mice underwent sham surgery or CLP at time 0.  Glucan phosphate was administered 1 h 
prior to surgery.   At 0, 3, 6, 12, and 24h resident peritoneal cells were harvested and assayed 
for Dectin-1 expression by flow cytometry.  Data were normalized to 0 h means.  
N=3/group/time point values are means ± SEM. * indicates p<0.05 compared to sham (A) and 
CLP (B). 
Changes in Overall Dectin-1 Expression in CLP Are Because of Changes in Cellular Dectin-1 
Expression and Changes in Cell Populations 
As with fungal sepsis 4 color analysis was performed to determine if changes in Dectin-1 
expressing cells were solely because of changes in Dectin-1 expression on individual cell types 
and/or the result of changes in cell population dynamics in response to sepsis and/or glucan 
treatment.  We found that sepsis and/or glucan treatment resulted in a decrease in the percentage 
of Dectin-1 positive blood neutrophils (Figure 23A and B).  Specifically, the percentage of 
Dectin-1 positive neutrophils was decreased at 3 h and 12 h after CLP when compared to control 
and sham surgery (Figure 23B).  The effect persisted at 12 h post-CLP (53.2 and 39.0%, p<0.05) 
(Figure 23C). Glucan treated CLP mice showed a 51.8% decrease (p<0.05) in the percentage of 
Dectin-1 positive blood neutrophils when compared to CLP alone at 3 hr post-operatively 
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(Figure 23B).  However, the effect was lost by 12 h (Figure 23C).  While the percentage of 
Dectin-1 positive neutrophils decreased, there was no significant change in the total percentages 
of blood neutrophil, monocyte, or lymphocyte cells, or in the percentage of Dectin-1 positive 
monocytes or lymphocytes in response to CLP or to glucan treatment with CLP (data not 
shown).  Thus, we conclude that the decrease in Dectin-1 positive blood leukocytes in CLP and 
in glucan treated CLP animals is because of a decrease in Dectin-1 surface expression in 
neutrophils, not a change in the total percentage of neutrophils.   
 
A. 
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In the spleen there was an 11.2% (p<0.05) decrease in the percentage of macrophages in 
CLP mice when compared to sham surgery controls 6 hr post-CLP (Figure 24A).  However, 
there was no change in the percentage of splenic Dectin-1 positive neutrophils, macrophages, or 
lymphocytes (data not shown).  Therefore, the decrease in splenic cells expressing Dectin-1 in 
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Figure 23  Sepsis decreases Dectin-1 expression on peripheral blood neutrophils 
 The administration of glucan results in a further decrement in neutrophil Dectin-1 positivity.  
Mice underwent no surgery (control), laparotomy (sham) control or CLP at time 0.  Glucan 
phosphate was administered 1 h prior to surgery. Blood was harvested at 3 (A and B) and 12 h 
(C), stained with anti-Dectin-1 and anti-neutrophil antibodies, and analyzed by flow 
cytometry.  Histograms were gated to the neutrophil population and the percentage of Dectin-
1 positive cells was determined.  A.  Representative histogram of 3 h data.  B and C.  Data are 
normalized to the no surgery control, which was set a 1.0. N=3/group, values are means ± 
SEM.  *p<0.05 compared to control; + p<0.05 compared to sham surgery and # p<0.05 
compared to CLP. 
CLP animals is because of a shift in cell populations rather than because of changes in Dectin-1 
expression by the various cell types.  With glucan treatment, CLP mice showed a significant 
increase of 76.0% in the percentage of Dectin-1 positive splenic macrophages at 3 h and a 
decrease of 43.5 and 51.6%  in the percentage of macrophage expressing Dectin-1 at 6 and 12 h, 
respectively, when compared to untreated CLP mice (p<0.05) (Figure 24B).  The percentage of 
Dectin-1 expressing splenic neutrophils were significantly increased at 12 h (47.2%, p<0.05) 
(Figure 24C).  There was no significant shift in cell populations at either time interval nor was 
there any change in the percentage of Dectin-1 expressing splenic lymphocytes (data not shown).  
We conclude that the decrease in overall splenic Dectin-1 positive cells with glucan treatment 
and sepsis (12 hr) is because of a decrease in the percentage of Dectin-1 positive splenic 
macrophages.  
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Figure 24  The decrease in the percentage of Dectin-1 positive splenocytes observed during 
sepsis is because of a reduction in the overall percentage of macrophages  With glucan 
treatment, the further decrease in the percentage of Dectin-1 positive splenocytes is because of 
a decrease in the percentage of Dectin-1 positive macrophages.  Mice underwent sham or CLP 
at time 0.  Glucan phosphate was administered 1 h prior to surgery.  At 0, 3, 6, 12, and 24h 
spleens were harvested, reduced to single cells, stained with anti- macrophage (A and B.), 
neutrophil (C.), and/or Dectin-1 (B and C.) antibodies, and analyzed by flow cytometry.  Data 
were normalized to 0h means which were set to 1.  N=3/group/ time point, values are means ± 
SEM.  * indicates p<0.05 compared to CLP. 
C. albicans and S. cerevisiae Glucans Decrease Dectin-1 Expression on Primary Neutrophils In 
Vitro 
In an effort to elucidate the mediators inducing the changes in Dectin-1 surface 
expression on circulating neutrophils in vivo with fungal and polymicrobial sepsis, thioglycollate 
elicited neutrophils were cultured with S. cerevisiae GP, C. albicans blastospore GP, C. albicans 
hyphal GP, LPS, mannan, or combinations of the different PAMPs.  The cells were evaluated for 
Dectin-1 expression by flow cytometry.  The GP from all sources resulted in a loss of Dectin-1 
from the neutrophil cell surface.  The S. cerevisiae GP reduced the percentage of Dectin-1 
positive cells by 51.02% (p<0.05) (Figure 25).  The C. albicans GP had similar effects on 
Dectin-1 expression with the blastospore GP decreasing the percentage of Dectin-1 positive cells 
by 57.63% (p<0.05) and the hyphal GP decreasing it by 54.22% (p<0.05) (Figure 25).  Neither 
the LPS alone nor the mannan alone significantly altered the expression on the cell surface, but 
the combination of LPS with S. cerevisiae GP and the combination of mannan with the C. 
albicans blastospore GP resulted in a reduction in the percentage of neutrophils expressing 
Dectin-1 (Figure 25).  The LPS/GP combination reduced the percentage of Dectin-1 expressing 
cells by 32.77% (p<0.05) and the mannan/GP combination reduced it by 57.15% (p<0.05) 
(Figure 25).  It can be concluded from these data that the loss of Dectin-1 from the neutrophil 
surface with candidiasis is because of GP released from either the blastospore or hyphal form.  In 
polymicrobial sepsis, the loss of Dectin-1 positive cells is not because of the effect of LPS, but 
may be because of circulating glucans released during sepsis (Digby et al. 2003).  However, the 
further loss of these cells with GP treatment is because of the effect of GP on Dectin-1. 
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Figure 25  S. cerevisiae and C. albicans derived glucans reduce the percentage of Dectin-1 
expressing elicited neutrophils alone and in combination with other PAMPs  Thioglycollate 
elicited neutrophils were incubated with 1 µg/ml S. cerevisiae GP, C. albicans blastospore or 
hyphal GP, LPS, or S. cerevisiae mannan alone or in combination for 3 h.  The cells were 
stained with anti-Dectin-1 and anti-neutrophil antibodies and analyzed by flow cytometry.  
The percentage of Dectin-1 positive cells within the neutrophil positive population was 
determined.  Average of 3 independent experiments with N=6, values are means ± SEM.  * 
indicates p<0.05 compared to control. 
 
 
Systemically Administered GP is Internalized by Blood, Splenic, and Peritoneal Leukocytes
The previous studies have determined that systemic infections modulate Dectin-1 
expression.  Additionally, the polymicrobial sepsis studies suggested that GP administration 
alone will also modulate Dectin-1; therefore Aim 3, focuses on the effect of systemic glucan 
administration on Dectin-1.  Though prior studies have shown that GP is internalized by Dectin-
1 expressing cells in vitro (Mueller et al. 1996; Herre et al. 2004), and we have shown that GP 
has biologic activity in vivo (Williams et al. 1978; Williams et al. 1991b; Williams et al. 1999b; 
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Williams et al. 2004a), previous studies have not determined if glucan is internalized by 
circulating leukocytes in vivo.  To address this issue, blood, splenic, and peritoneal leukocytes 
were harvested 5h after administration of fluorescent labeled GP using confocal microscopy.  
Five hours after IV administration, labeled glucan (green) could be seen within 1.86% of blood 
leukocytes, 93.67% of which were polymorphonuclear cells with the remainder being 
mononuclear cells (Figure 26).  Fluorescent labeled glucan was also detected within 1.91% 
splenic leukocytes (Figure 26).  Labeled glucan was also visible in the blood and spleen 5h after 
IP administration of fluorescent glucan (data not shown).  Five hours after IP administration of 
labeled GP, glucan could be detected in 86.20% of peritoneal leukocytes (Figure 26).  This 
indicates that systemically administered glucans are uptaken by circulating and tissue residing 
leukocytes. 
Figure 26  GP is internalized in vivo by blood, splenic, and peritoneal leukocytes  Mice 
were injected with fluorescent labeled GP (green, 5 mg/mouse) either IV or IP.  At 5 h after 
injection, blood, spleen and peritoneal leukocytes were harvested, counterstained with PI 
(red), and imaged using confocal microscopy. 
 
Parenteral Administration of GP In Vivo Induces a Prolonged Decrease in the Percentage of 
Dectin-1 Expressing Blood Leukocytes  
The previous experiment determined that glucans are internalized by circulating 
leukocytes.  To determine the long-term effect of glucans on Dectin-1 in these cells, Dectin-1 
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expression on mouse blood leukocytes was determined by flow cytometry 3 h, 1, 3, 5, 7, and 10 
d after IV and IP administration of GP.  Administration of GP resulted in a significant loss of 
Dectin-1 from peripheral blood leukocyte membranes (Figures 27A and B).  The Dectin-1high 
blood leukocytes were decreased by 42.8, 62.9, 83.1, 38.0, and 51.3% at 3h, 1, 3, 5, and 7d, 
respectively, with IV glucan when compared to control animals (p<0.05) (Figure 27B).  The 
percentage of Dectin-1high blood cells were significantly decreased by 81.0, 54.8, 47.3, and 
39.5% with IP glucan administration compared to control animals at 3 h, 1, 5, and 7 d, 
respectively (p<0.05) (Figure 27B).  These results are similar to those found with IV glucan 
administration.  Conversely, GP caused a significant increase in the percentage of Dectin-1low 
blood leukocytes when compared to controls (data not shown).  This likely represents a shift 
from the Dectin-1high phenotype to the Dectin-1low phenotype because of internalization of 
Dectin-1.  The increase with IV administration was 74.1, 157.8, and 54.9% on days 1, 3, and 5 
after injection, respectively, and 52.2, 204.2, and 37.6 on days 1, 3, and 5 after IP injection, 
respectively (p<0.05) (data not shown).  The percentage of both Dectin-1high and Dectin-1low 
cells returned to control levels by 7 days after injection in both IV and IP treated animals (Figure 
27B and data not shown).   
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Figure 27  GP treatment decreases the number of 
Dectinhigh positive blood leukocytes and peritoneal 
leukocytes  Mice were injected with GP (1 
mg/mouse) either IV or IP.  At 0, 3, 6, 12 h and 1, 3, 
5, 7, and 10 d after injection blood and peritoneal 
cells were harvested, stained with anti-Dectin-1 
antibody, and analyzed by flow cytometry.  A.  
Representative histogram of 3 d data.  B and C.  
Percent positive cells have been represented as a 
percentage of the control mean at each time point.  
N=3/group/time, values are means ± SEM.  * 
indicates p<0.05 comparing IV glucan to control 
and + indicates p<0.05 IP glucan compared to 
control. 
 
Intraperitoneal administration of glucan causes a substantial decrease in the percentage of 
Dectin positive peritoneal leukocytes, but this decrease is transient when compared to the 
changes found in the blood.  The percentage of Dectin positive peritoneal leukocytes was 
decreased by 63.1, 61.9, and 47.8% at 3, 6, and 12 h after IP injection and returned to normal 
levels by 24 h when compared to control mice (P<0.05) (Figure 27C).  Administration of GP 
also decreased the percentage of Dectin positive splenic leukocytes; however, a decrease of 
18.1% is significant only with IP administration on day 1 post-injection when compared to 
control (p<0.05) (data not shown).   
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Administration of GP Induces a Prolonged Loss of Dectin-1 Positivity in Peripheral 
Blood Neutrophils and Monocytes 
As with the sepsis studies, the cells responsible for the changes in overall Dectin-1 
expression were identified by 4 color flow cytometry.  Though there was a trend toward 
neutrophilia with both IV and IP injection of glucan, this increase was only significant with IV 
administration at 3 h (data not shown).  Neither IP nor IV administration of GP had an effect on 
the percentage of monocytes in the overall blood leukocyte population at any time interval 
compared to control (data not shown).  However, glucan administration affected the percentage 
of Dectin-1 expressing neutrophils and monocytes. Specifically, GP decreased the percentage of 
Dectin-1 expressing blood neutrophils (Figure 28A) and monocytes.  IV administration of glucan 
caused significant decreases of 49.5, 82.5, 64.3, 49.0% in the percentage of Dectin expressing 
blood neutrophils at 1, 3, 5, and 7 d after injection (Figure 28B), respectively, and significant 
decreases of 39.0, 74.5, and 33.4% in the percentage of Dectin-1 expressing blood monocytes at 
1, 3, and 5 d after injection (Figure 28C), respectively, when compared to control animals 
(p<0.05).  Administration of GP IP caused decreases of 84.9, 57.3, 64.6% in the percentage of 
Dectin-1 expressing blood neutrophils at 3 h, 3 d, and 5 d post-injection (Figure 28B), 
respectively, and decreased Dectin-1 expressing blood monocytes by 36.4, 34.6, 48.2% at 3h, 1d, 
and 3d post-injection (Figure 28C), respectively, when compared to controls (p<0.05).   
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Figure 28  GP treatment decreases the number of 
Dectin-1 positive blood neutrophils and 
monocytes  Mice were injected with GP (1 
mg/mouse) either IV or IP.  Blood was harvested, 
stained with anti-Dectin-1, anti-neutrophil, and 
anti-monocyte antibodies, and analyzed by flow 
cytometry.  Histograms were gated to the 
neutrophil (A and B) or the monocyte (C) 
population and the percentage of Dectin-1 
positive cells was determined.  A.  Representative 
histogram of 3 d neutrophil data.  B and C.  
Percent positive cells have been expressed as a 
percentage of the control mean at each time point.  
N=3/group/time, values are means ± SEM.  * 
indicates p<0.05 comparing IV glucan to control 
and + indicates p<0.05 IP glucan compared to 
control. 
 
 
Administration of GP Does Not Alter Membrane Dectin-1 Expression on Bone Marrow 
Precursors
 The data shown above demonstrate that GP will decrease the percentage of neutrophils 
and monocytes expressing membrane Dectin-1.  However, neutrophils and monocytes have a 
circulating half-life of hours to a few days.  In addition, Rice et al. have reported that 
parenterally administered GP has a plasma elimination half-life of 3.8 h (Rice et al. 2004). 
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Therefore, an important question was how a single injection of GP could result in such a 
prolonged loss of leukocyte membrane Dectin-1?  One possibility is that GP may also act at the 
level of leukocyte bone marrow precursors.  To answer this question, bone marrow cells were 
harvested from mice 1, 3, 5, 7, and 10 d after treatment with GP and evaluated for Dectin-1 
expression by flow cytometry.  GP administration had no significant effect on the percentage of 
Dectin expressing bone marrow cells when compared to control animals at any time interval 
(data not shown).  Therefore, Dectin-1 levels do not appear to be decreased in bone marrow 
precursors prior to their entry into the systemic circulation. 
 
The Effect of GP on Loss of Leukocyte Dectin-1 Levels is Specific and Not Observed with Non-
glucan Carbohydrate Polymers 
To examine the specificity of glucan on leukocyte membrane Dectin-1 expression, mice 
were injected with mannan, a fungal cell wall mannose polymer (Chauhan et al. 2002), and 
pullulan, an alpha-linked glucose polymer.  At 1 and 5 d after injection blood leukocytes were 
harvested and Dectin-1 expression and leukocyte phenotype was assessed using flow cytometry.  
As expected, GP resulted in significantly lower levels of leukocyte Dectin-1 when compared to 
controls (Figure 29A).  However, administration of mannan increased the percentage of Dectin-1 
expressing cells by 35.0 and 55.4% on days 1 and 5 after injection when compared to control 
animals (p<0.05) (Figure 29A).   
Leukocyte phenotypic analysis revealed that mannan increased the percentage of  Dectin 
expressing blood neutrophils by 5.8 and 3.1% (Figure 29B) and the percentage of Dectin 
expressing blood monocytes by 8.9 and 8.4% at 1 and 5d, respectively, when compared to 
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Figure 29  Non-glucan carbohydrates do not 
decrease Dectin-1 on blood leukocytes  Mice were 
given 1 mg GP, mannan, pullulan, or an equal 
volume of diluent at time 0.  Blood was harvested 
and the percentage of Dectin-1 positive leukocytes 
(A), neutrophils (B), and monocytes (C) were 
determined by flow cytometry.  Data were 
normalized to control means at each time point 
which were set to 100. N=3/group/time point, 
values are means ± SEM.  * indicates p<0.05 
compared to control. 
controls (p<0.05) (Figure 29C).  GP again resulted in a significant decrement in the percentage 
of Dectin-1 expressing neutrophils and monocytes (Figures 29B and C, respectively).  
Unlike GP, mannan administration significantly increased the percentage of neutrophils 
and monocytes.  The percentage of blood neutrophils was increased by 70.0% at 5 d after 
injection when compared to untreated controls (p<0.05) (Figure 30A).  The percentage of 
monocytes was elevated by 51.7% at 5 d when compared to untreated animals (p<0.05) (Figure 
30B).  Therefore, the increase Dectin positive blood leukocytes at 5 d is because both of an 
increase in Dectin positive neutrophils and monocytes and an increase in neutrophils and 
monocytes, cells known to express the highest levels of Dectin-1 on their surface.  Pullulan had 
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very little or no effect on the make-up of the cell population or the percentage of Dectin-1 
positive blood leukocytes at either time interval (Figure30).   These results indicated that the 
effect of GP on Dectin expressing blood leukocytes is specific to carbohydrates known to 
interact with the Dectin-1 receptor. 
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Figure 30  Administration of control the carbohydrate mannan increases the percentage of 
neutrophils and monocytes  Mice were given 1 mg GP, mannan, pullulan, or an equal volume 
of diluent at time 0.  Blood was harvested and the percentage of neutrophils (A.) and 
monocytes (B) was determined by flow cytometry.  Data were normalized to control means at 
each time point which were set to 1. N=3/group/time point, values are means ± SEM.  * 
indicates p<0.05 compared to control. 
 
 
The Effect of Glucans on the Loss of Leukocyte Dectin-1 Levels is Dependent on the Type of 
Glucan 
Glucans are found in the cells walls of not just fungi but also other microbes as well as 
plants.  Not all of these glucans are biologically active (Lowe et al. 2001).  Therefore, to 
determine if the effect of GP on Dectin-1 was specific to biologically active glucans, mice were 
injected with laminarin, a smaller molecular weight β-glucan that does not stimulate intracellular 
signaling (Lowe et al. 2001) and Dectin-1 expression and phenotype of blood leukocytes was 
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measured at 3 h and 1 d after injection.  Laminarin also resulted in a decrease in the percentage 
of Dectin-1high expressing blood leukocytes, but the effect was much more transient than that 
seen with GP.  Specifically, laminarin resulted in a 47.4% decrease in Dectin-1high expressing 
and a 72.1% increase in Dectin-1low expressing blood leukocytes when compared to control 
animals (p<0.05) (Figure 31A and data not shown).  However, by 24 h after injection, the 
number of Dectin-1high positive cells with laminarin treatment had returned to control levels.  As 
with GP, the changes seen in overall Dectin-1 expression with laminarin treatment are because 
of changes in the percentage of Dectin-1 expressing blood neutrophils (Figure 31B) and 
monocytes (Figure 31C).  At 3 h the percentage of Dectin-1 expressing blood neutrophils is 
significantly decreased by 23.5% with laminarin (p<0.05) (Figure 31B).  By 24 h, however, the 
percentage of Dectin-1 expressing neutrophils with laminarin treatment is not significantly 
different from control (Figure 31B).  The percentage of Dectin-1 positive blood monocytes was 
decreased by 22.44% compared to control at 3 h after laminarin injection (p<0.05) (Figure 31C).  
As with the Dectin-1 positive neutrophils, the percentage of Dectin-1 positive monocytes returns 
to control levels by 24 h (Figure 31C).  From these data we conclude that biologically inactive 
glucans, represented by laminarin, only transiently affect Dectin-1 expression when compared to 
a biologically active glucan, GP. 
B. C. 
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Effect of C. albicans Sepsis, Polymicrobial Sepsis, and GP Administration on Cytokines 
In Vivo 
Cytokines and chemokines are felt to play a critical role in stimulating an appropriate 
immune response to C. albicans infection (Mencacci et al. 1998), and the cytokine network is 
felt to be intimately involved in the pathophysiology of polymicrobial sepsis.  Additionally, 
Willment et al. have reported that GM-CSF, IL4 and IL-13 up regulate Dectin-1 expression, 
while IL-10 down regulates Dectin-1 expression in in vitro cultured macrophages (Willment et 
al. 2003).  For these reasons, changes in 10-16 different circulating cytokines and chemokines 
were measured in serum from mice with fungal sepsis, polymicrobial sepsis, and GP treatment 
were evaluated by Luminex analysis.   
In mice infected with C. albicans the serum concentrations of 16 cytokines and 
chemokines was measured on days 1, 3, 5, 7, and 14 of infection.  We found a significant 
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Figure 31  Administration of GP causes a prolonged decrease in Dectin-1 expression on 
blood leukocytes, whereas laminarin administration causes a transient decrease in Dectin-1 
expression on the same cell types  Mice were given either 1 mg glucan phosphate, 1 mg 
laminarin, or an equal volume of diluent at time 0.  Blood was harvested and the percentage 
of Dectin-1high positive leukocytes (A.), Dectin-1 positive blood neutrophils (B.), and 
Dectin-1 positive blood monocytes (C.) were determined by flow cytometry.  Data were 
normalized to control means at each time point which were set to 1. N=3/group/time point, 
values are means ± SEM.  * indicates p<0.05 compared to control. 
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elevation in the serum levels of  the inflammatory cytokines TNFα and IL-6 in C. albicans 
infected mice (Figure 32).  Serum TNFα increased by 49% (p<0.05) at day 14 after infection, 
when compared to controls (Figure 32A).  Serum IL-6 levels in infected mice were increased by 
643% at 7 days and by 599% (p<0.05) at 14 days (Figure 32B).  In contrast, the anti-
inflammatory cytokine IL-10 was significantly decreased by 22% (p<0.05) on day 7 post-
infection (Figure 32C).  The circulating levels of chemokines were variable throughout the 
study.  The neutrophil chemokine IL-17 (Figure 32D) was increased by 170% at day 14 in 
infected mice when compared to non-infected controls.  MIP-1α, a monocyte, macrophage, and 
T lymphocyte chemokine, was decreased by 40.2% (p<0.05) at 7 days when compared to control 
values (Figure 32E).  Interestingly, MIG, an IFNγ stimulated chemokine for activated 
lymphocytes, was increased by 119% (p<0.05) on day 1 (Figure 32F).  However, we were unable 
to detect a difference in IFNγ between control and C. albicans infected mice at any time 
throughout the study, though there was a trend toward elevation on day 1 (data not shown).  
Additionally, we were unable to detect any change in the systemic concentrations of the 
remaining Th1 cytokines (IL-12) or Th2 cytokines (IL-4) with C. albicans infection (data not 
shown). 
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Figure 32 C. albicans infection increases serum concentration of pro-inflammatory cytokines 
and chemokines Mice were injected on day 0 with 1x105 cfu C. albicans.  Serum was 
harvested at various time intervals after fungal challenge and cytokine/chemokines were 
assayed using a multiplexed bead assay kit.  Concentrations were normalized to the control 
concentrations at each time interval which were set to 1.  N = 5/group/time interval. values 
are means ± SEM.   * indicates p<0.05 compared to control.
1 3 5 7 13 14
In
te
rle
uk
in
 1
0
(N
or
m
al
iz
ed
)
0.6
0.8
1.0
1.2
1.4
Control 
Candida 
Days
1 3 5 7 14
In
te
rle
uk
in
 1
7
(N
or
m
al
iz
ed
)
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Control 
Candida 
Days
1 3 5 7 14
M
IP
-1
(N
or
m
al
iz
ed
)
0.4
0.6
0.8
1.0
1.2
1.4 Control 
Candida 
Days
1 3 5 7 14
M
IG
(N
or
m
al
iz
ed
)
0.5
1.0
1.5
2.0
2.5
3.0
Control 
Candida 
*
* *
*
*
*
*
C. D. 
E. F. 
88 
In mice that underwent CLP, serum was harvested at 12 h post-operatively and analyzed 
for 10 different cytokines.  CLP had a significant effect on the concentration of circulating pro-
inflammatory cytokines.  Specifically, CLP increased TNFα expression (p<0.01) when 
compared to the control (533%) and sham (546%) groups, respectively (Figure 33A).  IL-6 
levels were increased by 190 fold in CLP versus control and 61 fold versus sham (Figure 33B, 
p<0.01).    Likewise, IL-1β levels were increased by 75% in CLP mice relative to the controls 
(Figure 33C, p<0.02). CLP also increased the anti-inflammatory cytokine IL-10 by 55 fold when 
compared to the control group (p<0.01) (Figure 33E).  There was no difference in the levels of 
IFNγ, GM-CSF, IL-2, IL-4, or IL-5 between the CLP group and the control and sham groups 
(data not shown).  Administration of glucan to CLP mice did not significantly alter cytokine 
levels; however, TNFα, INFγ, GM-CSF, IL-2, IL-6, IL-10, and IL-12 levels showed a downward 
trend when compared to the CLP group (Figure 33 and data not shown). Glucan administration 
did not alter serum cytokine levels in sham surgery mice, but did reduce IL-2 levels by 11% 
(p<0.01) in the glucan alone group (Figure 33F). 
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Figure 33  Polymicrobial sepsis induces production of pro-inflammatory and anti-
inflammatory cytokines Mice underwent sham or CLP at time 0.  Glucan phosphate (1 
mg) or diluent was administered 1 h prior to surgery.  Serum was obtained 12 hours post-
operatively and assayed using a Luminex multiplex mouse cytokine kit.  N=5/group, 
values are means ± SEM.   *indicates p<0.05 compared to control and + indicates p<0.05 
compared to sham. 
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In GP treated mice serum concentrations of 16 cytokines and chemokines were measured 
at 0, 3, 24, and 72h after IV injection.   We found that administration of GP caused a significant 
increase in the neutrophil chemokines KC and IL-17 24h after injection when compared to 0 h 
controls.  Specifically, KC concentrations were increased by 57.84 % (p<0.05) (Figure 34) and 
IL-17 concentrations were increased by 2047% (p<0.05) (Figure 34).  Interestingly, even though 
concentrations of INFγ were unaffected by GP administration (data not shown), the 
concentrations of the interferon induced chemokines IP-10 and MIG were both elevated 3h after 
glucan treatment.  IP-10 was increased by 290.9% (p<0.05) (Figure 34) and MIG was increased 
by 687.2% (p<0.05) (Figure 34) when compared to 0 h control levels.  Concentrations of MCP-1 
were also increased by 601.4% 3h after injection when compared to 0h controls (p<0.05) (Figure 
34).  24h after injection with GP, IL-12 was decreased by 56.29% (p<0.05) (Figure 34).  
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Figure 34  GP stimulates granulocyte and monocyte chemokine production while decreasing 
the immunomodulatory cytokine interleukin 12  Mice were injected with GP (1 mg) IV.  At 0, 
3, 24, and 72 h after injection serum was harvested and assayed for 16 cytokines and 
chemokines by Luminex assay.  Concentrations were normalized to the 0 h means which were 
set to 1. N=4 animals/ time point, values are means ± SEM.  * indicates p<0.05 compared to 0 
h control.  
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GP Co-Localizes With Dectin-1 upon Internalization 
 The previous in vivo study demonstrates that circulating leukocytes internalize GP, and 
treatment with GP results in a loss of Dectin-1 from the cell surface.  We and others have 
reported that macrophages internalize Dectin-1 in response to GP treatment(Mueller et al. 1996; 
Herre et al. 2004). However, there is no evidence to indicate whether the GP and Dectin-1 are 
internalized and co-localized within the leukocyte. We examined the internalization and co-
localization of GP and Dectin-1. Incubation of murine peritoneal macrophages with fluorescent 
labeled GP resulted in uptake of the GP (green, Figure 35A).  In the cells that do not contain 
glucan, Dectin-1 is primarily membrane associated (red, Figure 35B). In the cell containing GP, 
the GP co-localized with Dectin-1 in an intracellular vesicle (yellow, Figure 35D).  Co-
localization with Dectin-1 was found in a mean of 62.16% of cells containing GP (data not 
shown). We interpret these data to mean that glucans are internalized and co-localized with 
Dectin-1 in leukocytes. 
 
 
B. C. D. A. 
Figure 35  Co-localization of GP with Dectin-1 in primary murine macrophages 
Thioglycollate elicited macrophages were incubated for 10 m with fluorescent labeled GP (A, 
green), stained with anti-Dectin-1 antibody (B, red), and counterstained with Sytox green 
nuclear counterstain (C, blue).  Images were analyzed by confocal microscopy.  Co-
localization is shown as yellow (D). Analysis of the co-localized image indicated a mask 
intensity of >71% which confirms that glucan phosphate co-localizes with Dectin-1 in murine 
leukocytes. 
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GP Co-Localizes with Clathrin and Caveolin-1 upon Internalization by Macrophages 
 Aim 3 determined that Dectin-1 is lost from the cell surface because of internalization of 
the Dectin-1/glucan complex.  In Aim 4 the mechanisms by which the Dectin-1/glucan complex 
is internalized and trafficked was determined.  Aim 4 also addresses any differences in 
trafficking amongst different types of glucans.   
The 2 primary mechanisms for internalization are clathrin mediated and non-
clathrin/lipid raft mediated (Le Roy and Wrana, 2005).  To determine which of these 
mechanisms is responsible for Dectin-1/glucan internalization, primary macrophages were 
incubated with fluorescent labeled glucan (green, Figures 36A and E) and stained with 
antibodies against clathrin (red, Figure 36B) or caveolin-1 (red, Figure 36F).  Caveolin-1 is a 
tyrosine kinase found in the lipid raft and involved in lipid raft mediated internalization (Le Roy 
and Wrana, 2005).  The cells were analyzed by confocal microscopy.  Interestingly, GP co-
localized with both clathrin (yellow, Figure 36C) and caveolin-1 (yellow, Figure 36G) after 15 m 
incubation.  Co-localization can better be seen in the masked image (white, Figures 36D and H).  
The mean percentage of cells positive for co-localization of GP with clathrin was 90.00% and 
with caveolin-1 was 83.33% at 15 m.  Both proteins were also found to co-localize with GP at 5 
m (data not shown).  At 5 m a mean of 63.89% of cells were positive for co-localization of GP 
with clathrin, and a mean of 100% were positive for co-localization of GP with caveolin-1.  In 
some cases a receptor can be internalized by either clathrin mediated or caveolin/lipid raft 
mediated mechanisms (Di Guglielmo et al. 2003); further studies were necessary to determine if 
this was the case with the Dectin-1/GP complex. 
Caveolin 
A. B. C. D. A. 
E. F.E. G. H. 
Clathrin 
Figure 36  GP co-localized with both caveolin-1 positive vesicles and clathrin positive 
vescicles  Thioglycollate elicited murine macrophages were incubated with fluorescent labeled 
GP (green, A and E) for 15 min and then stained with labeled anti-caveolin-1 (red, B) or anti-
clathrin heavy chain (red, F) antibody.  Co-localization is shown in yellow in the overlay 
image (C and G) and in white in the masked image (D and H).  A mask intensity rate ≥ 35% 
was considered positive.  Representative images. 
 
GP is Internalized by Clathrin Mediated Endocytosis in Macrophages
The previous co-localization study demonstrated that GP is co-localized with both 
caveolin-1 and clathrin.  This suggests that GP is internalized by both clathrin and caveolin/lipid 
raft mediated mechanisms.  To determine if this is the case, macrophages were incubated with 
hyperosmotic sucrose, which inhibits clathrin mediated uptake, or with MβCD, which depletes 
cholesterol and inhibits uptake by lipid rafts.  Upon treating the cells with fluorescent labeled 
glucan, we found that the percentage of Dectin-1 positive macrophages was decreased by 
18.49% (p<0.05) (Figure 37A) while the mean fluorescence of glucan in the cells was increased 
by 1431% (p<0.05) (Figure 37B) when compared to untreated cells.  This represents 
internalization of the Dectin-1/glucan complex.  Pre-treatment with hyperosmotic sucrose alone 
did not significantly affect the amount of Dectin-1 on the cell surface when compared to control 
cells (p>0.05) (Figure 37A).  Furthermore, incubation of the sucrose treated cells with glucan did 
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Figure 37  Internalization of the Dectin-1/glucan complex is mediated by clathrin.  
Thioglycollate elicited macrophages were incubated with media alone or fluorescent labeled 
GP (10 µg/ml) for 3 h.  Treated cells were pre-incubated with MβCD (5 mM) or sucrose (500 
mM) for one hour. Cells were stained with anti-Dectin antibody and analyzed by flow 
cytometry for Dectin-1 expression (A.) and glucan uptake (B.).  Data represent the mean of 4 
independent experiments with n=3.  * indicates p<0.05 compared to untreated control and + 
indicates p<0.05 compared to untreated glucan. 
not change the amount of Dectin-1 on the cell surface while increasing the glucan fluorescence 
by 775% when compared to controls (p<0.05) (Figures 37A and B, respectively).  This indicates 
that the sucrose is inhibiting Dectin-1/glucan internalization suggesting that glucan is being 
internalized by a clathrin mediated mechanism.  In contrast, MβCD treatment alone decreased 
Dectin-1 surface expression by 31.75% when compared to untreated cells (p<0.05) (Figure 37A).  
Glucan treated MβCD cells had a 37.27% decrease in the percentage of Dectin-1 positive cells 
when compared to MβCD alone, and a 57.18% decrease when compared to untreated control 
cells (p<0.05) (Figure 37A).  Interestingly, the MβCD treated cells internalized twice as much 
glucan than untreated cells with a 56.35% increase in the mean glucan fluorescence when 
compared to glucan treatment alone (p<0.05) (Figure 37B).   
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To confirm these data and to explain the slight increase in glucan fluorescence with 
hypertonic sucrose, macrophages were pre-incubated with hypertonic sucrose, MβCD, or media 
alone followed by incubation with fluorescent labeled glucan (green, Figure 38) for 6 h.  The 
lipid rafts were stained (red, Figure 38) and the cells were imaged by confocal microscopy.  The 
images confirm that hypertonic sucrose decreases the uptake of glucan by macrophages (Figure 
38C) when compared to the untreated cells (Figure 38A).   Additionally, the majority of glucan 
present with sucrose treatment was found extracellularly (Figure 38C).  MβCD treatment was 
again found to increase glucan uptake (Figure 38B) when compared to the untreated image 
(Figure 38A).  These data confirm that glucan internalization is clathrin dependent; however, 
lipid rafts appear to play a role in the regulation of internalization of glucans by macrophages.   
 A. Figure 38  GP internalization is mediated by 
clathrin Thioglycollate elicited 
macrophages were incubated with media 
alone or fluorescent labeled GP (green, 100 
µg/ml) for 6 h.  Treated cells were pre-
incubated with media alone (A), MβCD 
(B), or hypertonic sucrose (C) for 1 hour.  
Cells were fluorescently stained for lipid 
rafts (red) and imaged by confocal 
microscopy.  Representative images. 
B. C.
To further elucidate the role of lipid rafts and caveolin in the internalization of Dectin-
1/glucan complexes, macrophages from caveolin-1 knock-out (Cav-/-) and wild type (WT) mice 
were incubated with fluorescent labeled glucan, stained for Dectin-1 expression, and analyzed by 
flow cytometry.  The percentage of Dectin-1 expressing Cav-/- macrophages was significantly 
less than that of WT (89.65% vs. 62.73%, respectively) (Figure 39A).  Though there was no 
difference in the decrease in the percentage of Dectin-1 positive cells with glucan treatment 
between Cav-/- and WT cells (12.49% vs. 12.79%, respectively) (Figure 39A), the gluca mean 
fluorescence of Cav-/- cells was 90.95% higher than WT cells (Figure 39B).  These data again 
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suggest a regulatory role for lipid rafts and caveolin-1 in the internalization of Dectin-1/glucan 
complexes, and demonstrate that internalization is not mediated by lipid rafts or caveolin-1. 
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Figure 39  Internalization of the Dectin-1/glucan complex is enhanced in macrophages from 
caveolin-1 knock-out mice  Thioglycollate elicited macrophages from caveolin-1 knockout 
(Cav-/-) and wild type (WT) mice were incubated with fluorescent labeled glucan for 3 h.  The 
cells were stained with anti-Dectin-1 antibody and analyzed for Dectin-1 expression (A) and 
glucan uptake (B) by flow cytometry.  Average of 3 independent experiments with n=3, values 
are means ± SEM.  * indicates p<0.05 compared to WT control, + indicates p<0.05 compared to 
WT glucan. 
 
GP is not Trafficked to Lysosomes in Macrophages 
 The previous data have demonstrated that GP is internalized by a clathrin mediated 
mechanism; however, it is not known how the GP is trafficked after it has been internalized.  
Conventional wisdom implies that GP is trafficked via endosomes and to lysosomes (McCann et 
al. 2005).  To determine if this is the case, thioglycollate elicited macrophages were incubated 
with fluorescent labeled glucan (green, Figures 40A and 41A and E).  The cells were fixed, 
permeablized, and stained with antibodies against lysosomes (lamp1) (red, Figure 40B) or 
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endosomes (rab5b) (red, Figures 41B and F).   Analysis by confocal microscopy revealed that 
GP does not co-localize with lysosomes (yellow and white, Figures 40C and D, respectively).  
Less than 20% of cells were positive for co-localization of GP with lamp-1 at any time interval 
tested.   
 
A. B. C. D. 
Figure 40  GP is not trafficked to Lamp1 positive vesicles (lysosomes) in macrophages  
Thioglycollate elicited murine macrophages were incubated with fluorescently labeled 
glucan phosphate (green, A) for 30 m and then stained with labeled anti-Lamp1 (red, B) 
antibody.  Co-localization is shown in yellow in the overlay image (C) and in white in the 
masked image (D).  A mask intensity rate ≥ 35% was considered positive.  Representative 
images.  
However, confocal analysis did not conclusively determine if GP was trafficked via 
endosomes as co-localization with endosomes was quite variable from experiment to experiment.  
At the 30 m incubation time, for example, one experiment found 0% of the cells had GP co-
localized with rab5 (yellow and white, Figure 41C and D, respectively), but in another 100% of 
the cells had GP co-localized with endosomes (yellow and white, Figures 41G and H, 
respectively.  These data suggest that GP can be both trafficked via endosomes and via an 
alternate pathway; perhaps caveosomes.   
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B. C. A. D. 
E. F. G. H. 
Figure 41  GP is trafficked by rab5B positive vesicles (endosomes) and by another type of 
vesicle in macrophages  Thioglycollate elicited murine macrophages were incubated with 
fluorescently labeled glucan phosphate (green, A and E) for 30 m and then stained with 
labeled anti-rab5B antibody (red, B and F).  Co-localization is shown in yellow in the overlay 
image (C and G) and in white in the masked image (D and H).  A mask intensity rate ≥ 35% 
was considered positive.  Representative images. 
 
 
GP is Trafficked to the Golgi Apparatus in Macrophages 
 As the lysosome has been ruled out as a destination for internalized glucan, alternate 
organelles were explored.  Primary macrophages were incubated with labeled glucan (green, 
Figure 42A) and then stained for the Golgi apparatus (GM130) (red, Figure 42B), endoplasmic 
reticulum (GRP78) (data not shown), and the mitochondria (data not shown).  Confocal analysis 
revealed that GP did not co-localize with either the endoplasmic reticulum or the mitochondria 
(data not shown).  However, GP did co-localize with the Golgi apparatus (yellow, Figure 42C), 
with 100% of cells having a mask intensity rate greater than 35% at the 1 h incubation time 
(white, Figure 42D).  Additionally, in 100% of cells GP was found to co-localize with the Golgi 
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apparatus at 30 m. These data indicate that GP is internalized by clathrin and trafficked by 
endosomes and other vesicles to the Golgi apparatus. 
 
A. B. C. D. 
Figure 42  GP is trafficked to the Golgi apparatus in macrophages  Thioglycollate elicited 
murine macrophages were incubated with fluorescently labeled glucan phosphate (green, A) 
for 1 h and then stained with labeled anti-GM130 antibody (red, B).  Co-localization is shown 
in yellow in the overlay image (C) and in white in the masked image (D).  A mask intensity 
rate ≥ 35% was considered positive.  Representative images. 
 
GP Co-Localizes with the Signaling Components P85, SR-A, and TLR2 in Macrophages 
 Previous studies have revealed that GP activates the PI3K signaling pathway (Williams et 
al. 2004a).  Additionally, GP has been found to bind to scavenger receptor A (SR-A) (Rice et al. 
2002).  Finally, Dectin-1 signaling has been found to occur by both TLR2 dependent and 
independent pathways (Brown et al. 2003; Gantner et al. 2003).  To determine if the Dectin-1/GP 
complex directly interacts with these signaling components, elicited macrophages were 
incubated with fluorescent labeled GP (green, Figures 43, 44, and 45A), fixed, and permeablized, 
and stained for the regulatory subunit of PI3K (p85) (red, Figure 43B), SR-A, (red, Figure 44B) 
and TLR2 (red, Figure 45B).  P85 was found to consistently co-localize with GP in the majority 
of cells at time intervals from 5 m to 1 h (yellow, Figure 43C).  At 5 m GP was co-localized with 
p85 in 100% of GP containing cells (white, Figure 43D).  The same was true for the 15, 30 m, 
and 1 h incubations (data not shown).   This implies that p85 is present on the membrane of the 
GP containing trafficking vesicle as well as on the membrane of the Golgi apparatus.   
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A. B. C. D. 
Figure 43  GP co-localizes with the p85 regulatory subunit of PI3K in macrophages  
Thioglycollate elicited murine macrophages were incubated with fluorescently labeled glucan 
phosphate (green, A) for 30 m and then stained with labeled anti-p85 antibody (red, B).  Co-
localization is shown in yellow in the overlay image (C) and in white in the masked image 
(D). A mask intensity rate ≥ 35% was considered positive for co-localization.  Representative 
image. 
 
GP was also found to co-localize with SR-A at time intervals from 5 m to 30 m, with 
100% of GP containing cells being positive for co-localization with SR-A at 5, 15, 30 m, and 1 h 
(yellow or white, Figure 44C and D, respectively, and data not shown).  This suggests that SR-A 
is being internalized with the Dectin-1/glucan complex and is trafficked with GP inside the cell.  
  
A. B. C. D. 
Figure 44  GP co-localizes with scavenger receptor A after uptake by macrophages  
Thioglycollate elicited murine macrophages were incubated with fluorescently labeled glucan 
phosphate (green, A) for 15 m and then stained with labeled anti-SRA antibody (red, B).  Co-
localization is shown in yellow in the overlay image (C) and in white in the masked image (D). 
A mask intensity rate ≥ 35% was considered positive. 
 
Finally, confocal analysis revealed that GP co-localized with TLR2 in 100% of GP 
containing cells from 5 m to 1 h (yellow or white, Figure 45C and D, respectively, and data not 
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shown).  These data imply that TLR2 is also internalized with the Dectin-1/glucan complex and 
trafficked within the cell with GP. 
A. B. C. D. 
Figure 45  GP co-localizes with Toll-Like Receptor 2 at 1 hour after internalization by 
macrophages.  Thioglycollate elicited murine macrophages were incubated with fluorescently 
labeled glucan phosphate (green, A) for 1h and then stained with labeled anti-TLR2 antibody 
(red, B).  Co-localization is shown in yellow in the overlay image (C) and in white in the 
masked image (D). A mask intensity rate ≥ 35% was considered positive for co-localization.  
Representative image. 
 
Different Types of Glucans are Similarly Trafficked by Macrophages 
 As previously mentioned, different glucans have different activities in vivo.  For example, 
GP is protective in sepsis and causes a prolonged decrease in Dectin-1 surface expression on 
blood neutrophils.  Laminarin, a soluble glucan that is derived from Laminaria digitata, does not 
protect in sepsis and only transiently decreases Dectin-1 on neutrophils.  It is possible that the 
differences in activity, especially in regards to Dectin-1 surface expression, may be because of 
differences in trafficking.  In fact, Herre et al. have reported that upon internalization with GP 
Dectin-1 is degraded, but that when internalized with laminarin it is recycled back to the cell 
surface.  To determine if laminarin is trafficked differently from GP, fluorescent labeled 
laminarin (green, Figures 46A, E, I, M, and Q) was incubated with thioglycollate elicited 
macrophages, and then the cells were stained for clathrin (heavy chain), caveolin-1, endosomes 
(rab5), Golgi apparatus (GM130), or lysosomes (lamp1) (red, Figure 46B, F, J, N, and T, 
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respectively).  Confocal microscopy revealed that, unlike GP, laminarin does not co-localize 
with clathrin (yellow and white, Figures 46C and D, respectively); however, it does co-localize 
with caveolin-1 (yellow and white, Figures 46G and H, respectively).  Mask intensity analysis 
revealed that in 60.87% of cells laminarin co-localizes with caveolin-1 at 30 m and 62.50% are 
co-localized at 1 h.  This suggests that laminarin is internalized by a lipid raft/caveolin mediated 
mechanism rather than clathrin mediated.  Unlike GP, laminarin does not co-localize with 
endosomes at any time interval tested (yellow and white, Figure 46K and L, respectively).  Like 
GP, laminarin does not co-localize lysosomes (yellow and white, Figures 46S and T, 
respectively), but, though it co-localize with the Golgi apparatus, co-localization is only seen in 
52.90% of cells at the 30 m incubation (data not shown) while 0% of cells had laminarin co-
localized with the Golgi at 1 h (yellow and white, Figure 46O and P, respectively).  These data 
suggest that intracellular trafficking of glucans is dependent upon their structure.  As laminarin is 
found to co-localize with caveolin-1 and only transiently with the Golgi apparatus, it is possible 
that the Dectin-1 and laminarin are being rapidly transported back to the cell surface.  This 
would explain the transient effect of laminarin on Dectin-1 expression on the cell surface.   
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Figure 46  Laminarin is internalized by Caveolin-1 positive vesicles  Thioglycollate elicited 
murine macrophages were incubated with fluorescently labeled laminarin (green, first 
column), and then stained with labeled antibodies against intracellular organelles (red, second 
column).  Co-localization of the laminarin with the organelle is indicated in the overlay image 
by yellow (third column) and by white in the masked image (fourth column). A mask intensity 
rate ≥ 35% was considered positive for co-localization. 
 
 
Particulate and Soluble GPs are Similarly Trafficked by Macrophages 
 The GP and laminarin used in the previous studies are soluble glucans.  To determine if 
trafficking of particulate glucans is similar to that of soluble glucans, thioglycollate elicited 
macrophages were incubated with fluorescent labeled particulate GP (green, Figures 47A, E, I, 
M, and Q).  Particulate GP is similar in activity to the soluble product in that it is protective in 
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polymicrobial sepsis (Williams et al. 1980).  The cells were fixed, permeablized, and stained 
with antibodies against clathrin (heavy chain), caveolin-1, endosomes (rab5), Golgi apparatus 
(GM130), and lysosomes (lamp1) (red, Figures 47B, F, J, N, and R, respectively).  Based on the 
fluorescent properties of the particulate ligand and a distribution analysis, the mask intensity rate 
for co-localization with the particulates was reduced to 20%.  Analysis revealed that only 
23.53% of cells were positive for co-localization between particulate GP and clathrin (yellow 
and white, Figures 47C and D, respectively).  However, 100% of cells were positive for co-
localization between particulate GP and caveolin-1 (yellow and white, Figures 47G and H, 
respectively).  Co-localization with endosomes was clearly evident in the case of the particulate 
GP with 85.71% of cells being positive (yellow and white, Figures 47K and L, respectively).  
Particulate GP also co-localizes with the Golgi apparatus at all time intervals tested with a mean 
of 68.56% of cells analyzed being positive for co-localization (yellow and white, Figures 47O 
and P, respectively).  Like other glucan ligands, particulate GP does not co-localize with 
lysosomes (yellow and white, Figures S and T, respectively) with a mean of 36.25% of cells 
found to have a mask intensity rate greater than 20%.  These data imply that particulate GP is 
internalized into a caveosome and trafficked by endosomes to the Golgi apparatus.   
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Figure 47  Particulate glucan is internalized by Caveolin-1 and Rab5B positive vesicles  It is 
trafficked to the Golgi but not to lysosomes. Thioglycollate elicited murine macrophages were 
incubated with fluorescently labeled particulate glucan (green, first column) and then stained 
with labeled antibodies against intracellular organelles (red, second column).  Co-localization 
of the glucan with the organelle is indicated in the overlay image by yellow (third column) and 
by white in the masked image (fourth column).  A mask intensity rate ≥ 20% was considered 
positive for co-localization. 
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CHAPTER 5 
 
DISCUSSION 
 
Previous studies have found that Dectin-1 is the primary PRR for (1→3)-(1→6)-β-D-
glucans (Brown and Gordon 2001; Willment et al. 2001; Brown et al. 2002; Taylor et al. 2002; 
Brown et al. 2003).  Brown et al. demonstrated that Dectin-1 mediates the immune response to 
fungal glucans, and Taylor et al. found that Dectin-1 is present on innate immune cells such as 
neutrophils, dendritic cells, and macrophages (Brown and Gordon 2001; Willment et al. 2001; 
Brown et al. 2002; Taylor et al. 2002; Brown et al. 2003).  Brown et al. suggested that Dectin-1 
is a sentinel receptor for fungal infection (Brown et al. 2003).  Though these studies have 
provided a wealth of important information regarding Dectin-1 and glucan, they were performed 
using cell culture or soluble Dectin-1.  No prior studies have addressed Dectin-1/glucan 
interactions in vivo.  Furthermore, the role of Dectin-1 in polymicrobial sepsis has not been 
investigated even though the ligand for Dectin-1 improves survival in polymicrobial sepsis.  The 
present work revealed the effects of fungal infection, polymicrobial sepsis, and glucan 
administration on Dectin-1 in vivo (Table 2).  
 
 
 
 
 
 
  
 
Study Condition Dectin Positive 
Leukocytes 
Dectin Positive 
Neutrophils 
Dectin Positive 
Monocytes Other 
C. albicans 
infection Increased No Change No Change 
Neutrophilia, 
Neutrophils with 
less Dectin-1 
Polymicrobial 
Sepsis Decreased Decreased No Change ------ 
Glucan 
administration Decreased Decreased Decreased 
Decreased 
Dectin-1 Positive 
Monocytes 
Table 2  Summary of the effects of fungal infection, polymicrobial sepsis, and glucan 
administration on Dectin-1 expression in the blood 
  
 
Dectin-1 Expression is Increased by C. albicans Infection 
In Specific Aim 1 we examined the effect of systemic C. albicans infection on Dectin-1.  
We found that following C. albicans infection there was an overall increase in Dectin-1 levels in 
the blood, spleen, and kidneys of infected mice.  The change in overall Dectin-1 levels in the 
blood and spleen were primarily because of an influx of Dectin-1 positive neutrophils, though 
the amount of Dectin-1 expressed by these cells was reduced.  In the kidney, Dectin-1 positive 
macrophages and neutrophils were found at foci of fungal infection.  We also observed that the 
overall percentage of T cells in the periphery and spleen was decreased in the response to 
candidiasis. However, the remaining T cell populations showed a higher percentage of Dectin-1 
expressing cells when compared to control.  These data demonstrate that Dectin-1 expression is 
altered by a clinically relevant fungal infection. 
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C. albicans infection induced a Dectin-1 positive neutrophilia and an infiltration of the 
kidneys with Dectin-1 expressing cells.  Neutrophils are the first line of defense against fungal 
infections (Romani 2004), thus it is not surprising that candidiasis induced neutrophilia.  Dectin-
1 is expressed at high levels on neutrophils  (Brown et al. 2002; Taylor et al. 2002).  Therefore, a 
Dectin-1 positive neutrophilia may be interpreted as an innate immune response to candidal 
infection.  However, the increase in Dectin-1 positive cells was not sufficient to clear the fungal 
pathogen as C. albicans continued to be cultured from kidneys at the onset of mortality.  The 
increase in Dectin-1 was also not sufficient to alter disease outcome because the mortality rate 
was 100% by day 21 of infection.  This may be because of the challenge dose of C. albicans that 
may have been of sufficient magnitude to overwhelm innate host defenses, leading to a 
productive infection and ultimately death of the host.  There are other possible explanations for 
this outcome. Recent data from Netea and colleagues have demonstrated that TLR2 knockout 
mice, which were challenged with C. albicans, showed increased rates of survival when 
compared to wild type mice (Netea et al. 2004).  The presence of TLR2 during candidiasis also 
resulted in increased production of IL-10, an anti-inflammatory cytokine that down regulates 
various aspects of immunity (Netea et al. 2004).  This indicates that TLR2 is not protective; 
rather it contributes to the pathophysiology of candidiasis.  Because Dectin-1 and TLR2 are 
known to collaborate in order to elicit an inflammatory response (Brown et al. 2003; Gantner et 
al. 2003), it is possible that Dectin-1, much like TLR2, may not play a protective role in response 
to C. albicans induced sepsis.  An alternative explanation may involve the loss of Dectin-1 on 
neutrophils.  Decreased neutrophil Dectin-1 levels may result in neutrophils that are less able to 
bind, internalize, and destroy fungal elements.  Additionally, the Dectin-1 positive cells found in 
the C. albicans containing renal lesions were primarily macrophages.  Macrophages are less 
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effective killers of C. albicans because the fungi are able to escape the phagolysosome and 
survive within the cell (Bodey 2000).  If the neutrophils in the renal foci of infection have lost 
Dectin-1 on their cell surface, they would be less able to bind, internalize, and destroy the 
pathogen.  This would allow for further growth of the organisms at each focus of infection.  We 
have determined the effect of C. albicans on Dectin-1 in vivo; however, the precise role of 
Dectin-1 in response to fungal infection will only be determined when studies with Dectin-1 
knockout mice are conducted. 
 
Dectin-1 Expression is Decreased by Polymicrobial Sepsis 
Specific Aim 2 determined the effect of a clinically relevant in vivo model of sepsis, with 
and without glucan administration, on cell surface Dectin-1 expression.  We found that 
polymicrobial sepsis decreased the number of Dectin-1high positive blood leukocytes while 
increasing the numbers of Dectin-1low positive cells.  This represents a shift from a high positive 
to a low positive phenotype by cells considered the first line of defense, neutrophils, and, to a 
lesser extent, monocytes.  Additionally, glucan administration in sepsis caused a further decrease 
in blood leukocyte Dectin-1 expression as well as a decrease in splenic and peritoneal cell 
Dectin-1 expression.  Again, a loss of cell surface Dectin-1 from neutrophils resulted in this 
decrease.  Because glucan administration in sepsis decreases Dectin-1 expression and improves 
survival, a loss of Dectin-1 on leukocytes positively correlates with improved survival.    
Glucan administration in polymicrobial sepsis decreased the percentage of Dectin-1 
positive neutrophils and peritoneal cells.  Though the decrease in Dectin-1 expression with 
glucan administration in sepsis is not surprising based on studies conducted with glucan 
administration in vitro, it is interesting to speculate how loss of cell surface Dectin-1 may 
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contribute to the improved survival found with glucan administration in sepsis.  One possibility 
may relate to the study by Ariizumi et al. who demonstrated that “Dectin-1 proteins… bind to 
putative ligand(s) on  T cells and deliver co-stimulatory signals” (Ariizumi et al. 2000).  Thus, 1 
way in which glucan may promote survival in sepsis is by preventing the interaction of Dectin-1 
with its T cell ligand. Further supporting this notion, studies indicate that interaction between T 
lymphocytes and monocytes or neutrophils, cells that express high levels of Dectin-1, results in a 
pro-inflammatory state (Li et al. 1995; Burger and Dayer 2002a; Burger and Dayer 2002b).  It is 
possible that the association of Dectin-1 with the T cell ligand is contributing to septic 
inflammation.  Loss of Dectin-1 from the cell surface because of glucan administration might 
prevent the interaction of Dectin-1 with the T cell ligand, thus, tempering the overall 
inflammatory state, and, thereby, promoting survival.  Identification of the T cell ligand for 
Dectin-1 and determination of the effect of the ligand’s interaction with Dectin-1 will provide 
further insight into the role of Dectin-1 in sepsis and possibly other inflammatory diseases as 
well. 
We demonstrated that polymicrobial sepsis decreased the percentage of neutrophils that 
express Dectin-1.  Because the effect of sepsis on Dectin-1 expression has not previously been 
investigated, the mechanisms that are responsible for the decrease in Dectin-1 expression have 
yet to be determined.  One possible explanation for this effect would be elevated levels of 
circulating glucans.  Digby et al. demonstrated that septic patients have an increase in circulating 
glucans regardless of infection type (Digby et al. 2003).  It has been proposed that in the 
critically ill, glucans translocate from the gut into the systemic circulation (Rice et al. 2005b).  In 
the present study, polymicrobial sepsis was induced by introduction of cecal contents into the 
abdominal cavity.  Not only is it possible that glucans are transolocating from the gut in this 
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model, but the ingesta from the cecum includes large numbers of microbes; therefore, the 
material extruded from the cecum into the peritoneal cavity contains glucan from the cell walls 
of these microbes.  The glucan from the peritoneal cavity could be absorbed into the systemic 
circulation, bind to Dectin-1, and cause Dectin-1 internalization and cell signaling.  
Alternatively, other factors have been shown to affect Dectin-1 expression (Willment et al. 
2003).  Willment et al. have reported that interleukin (IL)-10 and LPS negatively regulate 
Dectin-1 RNA expression in vitro (Willment et al. 2003).  The CLP model of polymicrobial 
sepsis results in elevated levels of circulating LPS and cytokines.  Studies have also shown that 
septic patients tend to have an increase in IL-10 (Marchant et al. 1994).  Any or all of these 
factors might contribute to the decreased cell surface expression of Dectin-1 that was observed; 
therefore, in vitro studies were performed to elucidate the mechanisms of decreased cell surface 
expression of Dectin-1.   
The in vivo studies demonstrated a differential effect on Dectin-1 expression with C. 
albicans infection and polymicrobial sepsis.  In polymicrobial sepsis there is a profound decrease 
in the percentage of neutrophils that express Dectin-1.  In C. albicans infection the percentage of 
Dectin-1 positive neutrophils remained unchanged, but the amount of Dectin-1 expressed by 
neutrophils was moderately decreased.  The in vitro studies were performed to determine the 
mechanism responsible for the observed differences.  We found that glucan administration alone 
resulted in loss of Dectin-1 from the neutrophil cell surface.  Non-glucan PAMPs such as LPS 
and mannan did not alter neutrophil Dectin-1 unless the cells were also treated with glucan. This 
suggests that glucans are the only PAMPs that affect Dectin-1 surface expression on neutrophils.  
Though it seems counter-intuitive, the in vivo and in vitro data together suggest that the levels of 
circulating glucans may be higher in mice with polymicrobial sepsis than in those with fungal 
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sepsis.  In fact, clinical studies by Digby et al. demonstrated that levels of circulating glucans in 
the critically ill were independent of the presence or type of infection (Digby et al. 2003).  These 
results may have clinical relevance.  It has been proposed that monitoring increases in serum 
glucan levels may be useful as a diagnostic assay for fungal infections (Kohno et al. 1993; Mori 
et al. 1997; Yoshida et al. 1997).  The FDA has recently approved a glucan specific serum assay 
as an indicator of fungal sepsis (Odavasi et al. 2004).  However, the present data as well as the 
previous clinical studies (Digby et al. 2003) suggest that measuring serum glucan levels as a 
positive predictive indicator for fungal infections is imprudent.  
  
Dectin-1 Expression is Decreased by Administration of Glucans
   Specific Aim 3 evaluated the effect of glucan administration on Dectin-1 expression.  
Previous studies have demonstrated that glucans are rapidly internalized by macrophage and 
monocyte cell lines, and that Dectin-1 is internalized in response to glucan treatment in cultured 
macrophages (Mueller et al. 1996; Herre et al. 2004).  We found that systemically administered 
glucans are uptaken from the circulation by peripheral leukocytes, and the glucan-Dectin-1 
complex is internalized and co-localized within the leukocyte.  Thus, we conclude that the loss 
of Dectin-1 from the leukocyte membrane is because of internalization of the glucan-Dectin-1 
complex, following receptor ligand interaction.  We also observed that a single injection of GP 
resulted in decreased peripheral leukocyte Dectin-1 positivity for up to 7 days.  Splenic and 
peritoneal leukocytes also showed a decrement in surface Dectin-1 following glucan 
administration, but the magnitude and duration was less than that observed in peripheral 
leukocytes.  While Dectin-1 levels were significantly decreased on circulating leukocytes in 
response to glucan, we did not observe a complete loss of leukocyte membrane Dectin-1.  The 
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maximum decrement was approximately 85%, even in the presence of a high loading dose of 
GP.  The loss of Dectin from the cell membrane was primarily observed in peripheral neutrophils 
and monocytes, though no dramatic changes were found in overall leukocyte numbers.  
Therefore, systemic administration of glucan results in a preferential decrease in neutrophil and 
monocyte Dectin-1 levels because of internalization of the glucan-Dectin complex but does not 
change the peripheral leukocyte levels.  
We determined that administration of GP reduced Dectin-1 expression on blood 
neutrophils and monocytes for up to 7 days.  The prolonged duration of effect of GP on Dectin-1 
levels was an unexpected finding for several reasons.  First, the effect of glucan on Dectin-1 was 
primarily observed in neutrophils and monocytes.  These leukocytes are present in the systemic 
circulation for relatively short time periods, i.e. hours or days.  Second, Rice et al. have reported 
that GP has a distribution half-life of 4.3 + 0.7 min, an elimination half-life of 3.8 + 0.8 hrs, a 
volume of distribution of 350 + 88 ml/kg and a clearance rate of 42 + 6 ml/kg hr from the plasma 
following IV administration (Rice et al. 2004).  Thus, the effect of glucan on leukocyte 
membrane Dectin-1 levels lasts beyond the expected half-life of neutrophils and monocytes and 
exceeds the anticipated clearance of the glucan from the systemic circulation.  As glucans have 
been reported to modulate leukocyte bone marrow precursors (Patchen and Lotzova 1980), 1 
possible explanation for the prolonged effect was that glucan administration altered Dectin-1 
membrane expression at the level of monocyte and/or neutrophil precursors in the bone marrow.  
However, we found that glucan did not alter Dectin-1 levels in bone marrow cells.  Another 
potential explanation for the prolonged effect of glucan administration on Dectin-1 cell surface 
expression may be recycling of the glucan.  Recent studies by Hong et al. suggest that orally 
administered water insoluble glucans are uptaken by macrophages and transported to the spleen, 
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lymph nodes, and bone marrow (Hong et al. 2004).  The authors speculated that the glucan was 
degraded and released into the systemic circulation where it was subsequently internalized by 
granulocytes (Hong et al. 2004).  However, mammalian cells do not have the enzymes necessary 
to specifically catabolize glucans (Stone and Clark 1992); therefore, a more reasonable 
explanation is that leukocytes which have bound and internalized glucan may release the glucan 
at the end of their lifecycle and it is then internalized by leukocytes which have recently entered 
the systemic circulation.  In support of this concept, Monari et al. have reported that neutrophils 
rapidly ingest glucuronoxylomannan and then subsequently released the carbohydrate (Monari et 
al. 2003).  This effect may not be limited to leukocytes. Receptors for glucans have been 
identified on vascular endothelial cells, epithelial cells, and fibroblasts (Ahren et al. 2001; 
Kougias et al. 2001; Lowe et al. 2002).  Thus, it is possible that glucans are uptaken from the 
systemic circulation by a variety of cells and tissues and are then slowly released over time to be 
internalized by newly released circulating leukocytes.  We also noted that membrane Dectin-1 
levels normalized by day 7 post-injection.  We know that Dectin-1 receptors do not recycle to 
the cell surface once they are complexed and internalized with a biologically active glucan such 
as glucan phosphate (Herre et al. 2004).  New receptors must be synthesized and expressed 
(Herre et al. 2004).  Thus, the re-appearance of leukocyte membrane Dectin-1 in our study may 
relate to prolonged elimination of the glucan from the body as well as synthesis of new receptor 
in some leukocytes. Further studies will be necessary to determine which mechanism(s) are 
primarily involved in the prolonged response to parenterally administered soluble glucans. 
In an attempt to better understand the role of Dectin-1 in the biologic activity of glucans, 
we compared and contrasted the effect of an inactive glucan, laminarin, on leukocyte membrane 
associated leukocyte Dectin-1 levels.  Laminarin was studied as it has been used for in vitro 
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studies as a Dectin-1 antagonist (Brown et al. 2002; Gantner et al. 2003).  Additionally, we have 
found that laminarin is not protective in sepsis; in fact, it actually shortens the time to mortality.  
Administration of laminarin reduced leukocyte cell surface Dectin-1, but the effect was quite 
transient when compared to GP.  The reason for the difference in effect on Dectin-1 expression is 
possibly related to the intracellular trafficking of Dectin-1 upon internalization with glucans.  
Previous studies have found that when Dectin-1 is internalized with laminarin, it is recycled to 
the cell surface (Herre et al. 2004).  When Dectin-1 binds and internalizes GP, the receptor does 
not recycle to the cell surface (Herre et al. 2004).  New receptor must be synthesized and 
expressed on the cell surface (Herre et al. 2004).  Interestingly, the duration of the effect of 
laminarin on Dectin-1 expression is similar to the circulating lifespan of neutrophils and 
monocytes.  It is reasonable to speculate that laminarin’s activity is limited only to the cells 
circulating at the time of administration.  Regardless of the underlying mechanism, the 
differential effect of laminarin, which does not protect in sepsis, and GP, which is protective in 
sepsis, on Dectin-1 expression further supports the notion that Dectin-1 plays a significant role in 
the protection conferred by Dectin-1 in sepsis. 
To determine the specificity of the effect of glucans on Dectin-1 expression in vivo, we 
compared and contrasted the effect of non-glucan carbohydrate polymers on leukocyte 
membrane associated leukocyte Dectin-1 levels.  We employed mannan and pullulan as control 
polymers for several reasons.  First, they are non-β linked carbohydrate polymers and they are 
not ligands for Dectin-1 (Brown et al. 2002).  In addition, mannan is a mannose polymer that is 
found in association with glucan in the fungal cell wall (Stone and Clark 1992).  The mannan 
employed in this study was isolated from the same fungal source as the GP (Peat et al. 1961).  
While pullulan had no effect on membrane Dectin-1 levels, we observed a differential effect of 
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GP and mannan on leukocyte Dectin-1 positivity.  While GP resulted in an overall loss of 
leukocyte Dectin-1 positivity, mannan resulted in a modest, but significant, increase in leukocyte 
Dectin-1 levels.  Thus, the loss of leukocyte membrane associated Dectin-1 is specific for glucan 
polymers and not a non-specific effect of carbohydrate polymers in general.  It is interesting to 
note that mannan also results in a neutrophilic leukocytosis.  This is similar to the effect of C. 
albicans infection.  It is highly possible that mannan from the C. albicans cell wall is responsible 
for the change in blood leukocyte population dynamics seen with C. albicans infection. 
The role of internalization of the Dectin-1/glucan complex in the biologic activities is 
controversial.  Numerous studies have shown that systemic administration of pharmaceutical 
grade glucans will stimulate innate immunity (Williams et al. 1999b), increase resistance to 
infectious challenge (Williams et al. 1978; Williams et al. 1982; Williams et al. 1988; Williams 
et al. 1991b), decrease myocardial injury following ischemia/reperfusion injury (Li et al. 2003), 
suppress the growth of transplanted tumors (Cheung et al. 2002; Hong et al. 2004), and facilitate 
wound repair (Wei et al. 2002).  The cellular and molecular mechanisms by which glucans 
mediate these effects are currently the subject of intense investigation (Williams et al. 1999b; 
Williams et al. 2004b).  Several investigators speculate that Dectin-1 mediates the biological 
effects of glucans (Brown et al. 2003; Gantner et al. 2003).  Indeed, it has been reported that 
ligation of Dectin-1 is sufficient to transduce an activating signal into macrophages and that 
internalization of the ligand-receptor complex is not required for induction of biological activity 
(Brown et al. 2003; McCann et al. 2005).  However, those experiments were performed with 
cultured cells, the stimulus was zymosan, a glucan-mannan cell wall extract, and the endpoint 
was cytokine production, not modification of disease (Brown et al. 2003).  In addition, we have 
shown that a single injection of glucan, either IV or IP, can induce biological effects lasting up to 
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7 days (Williams et al. 1999b).  This coincides with the period when leukocyte Dectin-1 levels 
are decreased.  This may indicate that binding and internalization of glucans by Dectin-1 are 
crucial to expression of in vivo biological activity.  As the Dectin-1 response to both IV and IP 
administration of GP are not significantly different at most time points, these data also support 
previous findings that both the IV and IP routes of administration are equally effective in 
modulating immune responses (Williams et al. 1999b).  These data may have significant 
implications for glucan dosing regimens. 
 
Modulation of Cytokines and Chemokines by C. albicans, Polymicrobial Sepsis, and Glucan 
Administration 
Cytokines and chemokines are integral to an appropriately functioning immune response.  
In the case of C. albicans infection, genetic depletion of TNFα, IL-6, IL-17, or IFNγ impairs the 
immune response to C. albicans and diminishes survival (Romani et al. 1996; Mencacci et al. 
1998; Balish et al. 1998).  An overproduction of inflammatory cytokines, including TNFα, IL-
1β, and IL-6, is thought to be a key mediator of sepsis syndrome (Damas et al. 1992; Pinsky et 
al. 1993).  Despite the fact that glucans have been found to stimulate the production of TNFα in 
vitro (Brown et al. 2003; Gantner et al. 2003), there are no data regarding the cytokine and 
chemokine profile of animals treated with glucans.   Furthermore, cytokines have been found to 
modulate Dectin-1 expression (Willment et al. 2003).  While cytokines and chemokines have 
been studied in C. albicans and in sepsis, only a few have been measured at a time because of 
technological constraints.  With the development of multiplex technology we were able to 
simultaneously measure up to 16 cytokines and chemokines in 1 sample.  This approach allowed 
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us to make the following new and novel observations regarding cytokine and chemokine 
dynamics in our in vivo models. 
 
The Cytokine and Chemokine Profile of Mice Infected with C. albicans 
We found that in C. albicans infection the inflammatory cytokines TNFα and IL-6 as 
well as the neutrophil chemokine IL-17 were elevated late in the course of disease, while the 
anti-inflammatory cytokine, IL-10, was decreased.  This inflammatory profile coincided with the 
onset of mortality.  Although these changes have been associated with candidiasis in the past 
(Steinshamn and Waage 1992; Huang et al. 2004), this is the first report of this particular 
temporal response. This may indicate that an overall inflammatory state is contributing to 
mortality in this model, as previous studies have shown that inflammatory cytokines, such as 
TNFα and IL-6, are associated with morbidity and mortality in response to infectious disease 
(Tracey et al. 1986; Bauss et al. 1987).       
IFNγ is thought to play an important role in innate host defense against C. albicans 
infection (Kullberg et al. 1993; Balish et al. 1998).  We were unable to detect a significant 
change in serum levels of IFNγ, although there was a trend towards increased levels on day 1.  
Interestingly, the IFNγ induced chemokine MIG was significantly increased in C. albicans 
challenged mice on day 1.  MIG is a chemoattractant for activated lymphocytes that is produced 
by antigen presenting cells (Park et al. 2002).  MIG is involved in recruitment of effector T cells 
to sites of peripheral cell mediated inflammation, notably in graft and tumor rejection 
(Tannenbaum et al. 1998; Koga et al. 1999; Miura et al. 2001). To the best of our knowledge, 
this is the first report of increased MIG levels in candidiasis. In this case, MIG may be involved 
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in initial recruitment of activated T lymphocytes to peripheral foci of C. albicans infection. This 
may account for the decrease in peripheral T cells observed during candidiasis.  
 
The Cytokine Profile of Mice with Polymicrobial Sepsis 
We found that CLP increased circulating levels of the pro-inflammatory cytokines TNFα, 
IL-6, and IL-1β.  Levels of the anti-inflammatory cytokine IL-10 were also increased.  This 
mixed inflammatory response is consistent with previous studies measuring cytokines in patients 
with sepsis (Damas et al. 1992; Pinsky et al. 1993; Marchant et al. 1994).  Because SIRS has 
been associated with elevations in pro-inflammatory cytokines (Brunn and Platt 2006), and GP 
improves survival in sepsis by tempering the NF-κB signaling pathway (Williams et al. 1999b), 
one would expect that GP administration would reduce pro-inflammatory cytokines to near 
normal levels.  However, this was not the case.  GP administration in sepsis had no significant 
effect on circulating cytokines when compared to CLP alone.  These data in combination with 
data showing that blocking inflammatory cytokine activity does not improve survival (Opal et al. 
1997; Clark et al. 1998) would seem to further reduce the importance of cytokines in the 
pathophysiology of sepsis. 
 
Cytokine and Chemokine Profile of Glucan Treated Mice 
Prior to the present study, pure GP was not thought to alter cytokine or chemokine 
production.  However, we have demonstrated that GP does alter cytokines and chemokines when 
administered parenterally.  Administration of a single injection of GP increased the circulating 
concentrations of the neutrophil chemokines KC and IL-17 and the monocyte chemokine MCP-
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1. GP also increased in the IFNγ dependent chemokines IP-10 and MIG and decreased the 
concentration of the Th1 regulatory cytokine IL-12, though it had no effect on the concentrations 
of IFNγ itself.  No changes were found in the concentrations of TNFα, IL-1β, or IL-6, the 
traditional pro-inflammatory cytokines.  Neither were changes found in the anti-inflammatory 
cytokine IL-10.   
Administration of GP induced the production of neutrophil chemokines 24 hours after 
injection.  Previous studies indicate that glucans stimulate neutrophil activity (Williams et al. 
1988; Tsikitis et al. 2004; Sato et al. 2006); however, the effect of glucans on neutrophils was 
assumed to be direct, i.e. by binding of glucan to Dectin-1 and other glucan receptor(s) that are 
present on neutrophils (Taylor et al. 2002).  Direct interaction may be one mechanism for the 
activation of neutrophils by glucans, but our data suggest an indirect activation of neutrophils by 
chemokines may occur as well.  Glucan administration stimulated an increase in the neutrophil 
stimulants KC and IL-17.  IL-17 is produced by T lymphocytes and is thought to be a link 
between the innate and adaptive immune response (Kawaguchi et al. 2004).  IL-17 stimulates the 
production of neutrophils by increasing the concentration of G-CSF (Kawaguchi et al. 2004).  As 
previously mentioned, IL-17 is necessary for the host immune response to C. albicans infection 
(Huang et al. 2004).  IL-17 may also be involved in glucan mediated protection in sepsis.  Rice 
et al. have demonstrated that administration of CpG DNA, a TLR9 ligand, is protective in CLP 
induced polymicrobial sepsis via an IL-17 dependent mechanism (Rice et al. 2005a).  It is 
possible that the same is true for glucan mediated protection.  Though IL-17’s effects are 
primarily on neutrophils, the IL-17 receptor is present on many different cell types (Kolls and 
Linden, 2004).  IL-17 induces production of KC by monocytes and macrophages and induces IP-
10 production by endothelial cells (Kawaguchi et al. 2004; Kolls and Linden, 2004).  Thus, the 
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increase in IL-17 concentration may also result in the changes in the levels IP-10 and KC found 
with GP administration.  These data suggest an alternative mechanism for activation of 
neutrophils by glucans. 
GP administration increased the T lymphocyte chemokines IP-10 and MIG.  These 2 
chemokines share a receptor and have similar effects (Farber 1997).  Both chemokines are 
produced by monocytes and macrophages and recruit activated T cells to the sites of production 
(Farber 1997).  Synthesis of both chemokines is stimulated by IFNγ, though other mediators will 
also induce their production (Farber 1997; Kolls and Linden, 2004).  Finally, both chemokines 
promote the generation of cell mediated immune responses and inhibit the humoral immune 
response (Farber 1997).  The effect of increased IP-10 and MIG levels with GP administration is 
unclear; however, an increase in the concentration of T lymphocyte chemokines by GP further 
supports the argument that the glucan specific receptor, Dectin-1, is a link between innate and 
adaptive immunity.  
By comparing the cytokine profile of mice injected with pure glucan with that of mice 
infected with whole C. albicans, we were able to isolate the effects of the fungal glucan on 
cytokine concentrations.  Increased concentrations of MIG and IL-17 were detected with both C. 
albicans infection and GP injection; therefore, it is likely that it is the glucan in the C. albicans 
cell wall that is inducing the production of these cytokines.  As GP did not induce production of 
the inflammatory cytokines TNFα or IL-6, these cytokines are being induced by another fungal 
PAMPs in the C. albicans cell wall. 
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Clathrin Mediated, Caveolin Regulated Internalization of Glucans 
Specific Aim 4 examined intracellular trafficking of glucans.  Previously it was assumed 
that glucans were internalized into endosomes and trafficked into lysosomes.  Recent studies by 
McCann et al. determined that glucans are internalized by a non-lipid raft mediated mechanism 
(McCann et al. 2005).  They also concluded that glucans were trafficked to lysosomes (McCann 
et al. 2005).  This study investigated only particulate glucans.  Additionally, regular fluorescent 
microscopy was used to determined co-localization (McCann et al. 2005).  We sought to gain 
additional insights into the trafficking of glucans by evaluating three different glucans using 
confocal microscopy.  We demonstrated that GP is internalized by a clathrin mediated 
mechanism that is regulated by caveolin-1 and/or lipid rafts (Figure 48).  We found that GP is 
trafficked to the Golgi apparatus, not to the lysosomes as previously assumed (Figure 48).  We 
also found that laminarin and particulate glucan are trafficked in a similar fashion.  Not 
surprisingly, GP co-localized with Dectin-1, but it also co-localizes with p85, SR-A, and TLR2 
(Figure 48).  These data support previous studies that indicate that these signaling components 
are involved in GP mediated signaling (Rice et al. 2002; Gantner et al. 2003; Williams et al. 
2004a).   
 
Figure 48  Schematic of glucan internalization and 
trafficking  Glucan is internalized with SR-A and TLR 2 
by clathrin and trafficked via early endosomes to the 
Golgi apparatus.  Internalization is negatively regulated 
by caveolin-1 by an unknown mechanism. 
 
The evidence for internalization of the Dectin-1/GP complex by clathrin is clear cut;  
however, the role of lipid rafts and caveolin-1 in internalization of the complex is less clear.  We 
have demonstrated that loss of caveolin-1 or lipid rafts results in enhanced internalization of GP 
despite a reduction in cell surface Dectin-1.  It was found that GP co-localizes with caveolin-1.  
These data suggest that caveolin-1 and lipid rafts are regulating Dectin-1 cell surface expression 
and internalization.  Caveolin-1 is known to interact with signaling molecules (Jayanthi et al. 
2004; Williams and Lisanti 2004c).   It is possible that Dectin-1 is normally sequestered into 
caveolae by caveolin-1, and internalization of GP by Dectin-1 is inhibited by this sequestration.  
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Loss of caveolae by disruption of lipid rafts or by genetic depletion of caveolin-1 relieves this 
inhibition allowing increased uptake of GP.   
It is interesting to note that glucans are transported to the Golgi apparatus after 
internalization rather than to lysosomes.  This is not an uncommon fate for PAMPs, as both LTA 
and LPS are transported to the Golgi apparatus after internalization (Thieblemont and Wright 
1999; Latz et al. 2002; Triantafilou et al. 2004a), but it raises the question of what happens to the 
glucans once they have reached the Golgi.  Mammalian cells do not possess the enzymes 
necessary for glucan catabolism (Stone and Clark 1992).  Therefore, there are 2 possibilities for 
the fate of glucans after they reach the Golgi:  the glucans may remain in the Golgi or another 
cellular compartment for the life of the cell or they may be transported out of the cell.   If the 
macrophage excretes the GP over time this would explain the prolonged effect of GP on Dectin-
1, as macrophages, and perhaps other cell types, could act as repositories for GP.  Additionally, 
when a neutrophil undergoes apoptosis, the apoptotic bodies are frequently ingested by 
macrophages (Meszaros et al. 2000).  This could lead to recycling of the GP contained within the 
neutrophil.  Recycling of glucan by macrophages and other cell types would explain the 
prolonged effect of GP. 
The trafficking studies demonstrate that laminarin and GP are trafficked in a similar 
fashion.  These data do not explain the differences in the effect of the glucans on Dectin-1 
expression, nor do they explain the work by Herre et al. that reports that Dectin-1 is degraded 
with GP but recycled with laminarin (Herre et al. 2004).  One explanation for this discrepancy 
would be that Dectin-1 is dissociating from the glucan at some point after internalization.  The 
Dectin-1 could then be processed differentially by the cell depending upon the ligand with which 
it was internalized.  This speculation is supported by studies investigating the trafficking of 
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TLR4 and LPS (Triantafilou et al. 2002; Triantafilou et al. 2004a; Triantafilou et al. 2004b; 
Husebye et al. 2006).  These studies demonstrated that TLR4 is trafficked to lysosomes where it 
is degraded, but the LPS is transported to the Golgi apparatus (Thieblemont and Wright 1999; 
Husebye et al. 2006).  This implies that the TLR4/LPS complex is dissociated prior to transport 
of the individual molecules to their final destination (Husebye et al. 2006).  Further studies will 
be necessary to determine the fate of Dectin-1 after internalization with glucan. 
In conclusion, we have confirmed the hypotheses that cell surface Dectin-1 is altered by 
fungal infection, polymicrobial sepsis, and glucan administration.  We have determined that 
glucan is the PAMP responsible for loss of Dectin-1 demonstrated in the in vivo models.  
Additionally, we have discovered the mechanisms of internalization and trafficking of glucans.  
These studies have provided the groundwork for a better understanding of the role of Dectin-1 
and glucan in the innate immune response. 
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APPENDIX 
 
Abbreviations 
 
AF   -Alexa Fluor™ 
ANOVA  -analysis of variance 
BAP   -blood agar plate 
Cav-/-   -caveolin-1 knock-out 
Cfu   -colony forming unit 
CLP   -cecal ligation and puncture 
CR   -complement receptor 3 
D5W   -5% dextrose in water 
DAP   -diaminopropane 
DMSO   -dimethyl sulfoxide 
G-CSF   -granulocyte colony stimulating factor 
GI   -gastrointestinal tract 
GM-CSF  -granulocyte monocyte colony stimulating factor 
GP   -glucan phosphate 
h   -hour 
H and E  -hemotoxylin and eosin 
IFNγ   -interferon gamma 
IL   -interleukin 
IP   -intraperitoneal 
ITAM   -tyrosine based activation motif   
IV   -intravenous 
LPS   -lipopolysaccharide 
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m   -minute 
MβCD   -methyl beta cyclodextran 
µg   -microgram 
mg   -milligram 
µl   -microliter 
ml   -milliliter 
mM   -millimolar 
NF-κB   -nuclear factor kappa B 
PAMP   -pathogen associated molecular pattern 
PAS   -periodic acid Schiff 
PBS   -phosphate buffered saline 
PEG   -polyethylene glycol 
PI3K   -phosphoinositide 3 kinase 
PRR   -pattern recognition receptor 
SIRS   -systemic inflammatory response syndrome 
SR-A   -scavenger receptor A 
SYK   -spleen tyrosine kinase 
TLR   -toll like receptor 
TNFα   -tumor necrosis factor alpha  
TRITC   -rhodamine 
WT   -wild type 
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